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 Introduction 
 Introduction 1.
 Nanomedicine and thermal therapies 1.1. 
In 1959, with his famous talk “There’s plenty of room at the bottom” [1], 
Richard Feynman officially introduced the world to an upcoming scientific 
revolution. His prospective, on the possibility for man to manipulate matter at 
its basilar elements, or single atoms, was later named “Nanotechnology” by 
Norio Taniguchi in 1974 [2]. This name inspired countless investigations 
amongst scientists and unbound intrigue by novelists. Finally, they were the 
’80s to see Nanotechnology emerged as a proper scientific field: in 1981 the 
invention of the Scanning Tunneling Microscope (for which Gerd Binnig and 
Heinrich Rohrer were awarded the Nobel Prize in Physics, 1986) allowed first-
time visualization of single atoms; in 1985 Smalley and coworker “build” the 
first molecular compound not available in nature (C60, the Fullerene and were 
awarded with the Nobel Prize in Chemistry, in 1996) [3]. In 1986 with his 
book “Engines of Creation” [4] , Drexler provoked the imaginations of many, 
foreseeing the time when nanoscaled “assemblers” will be able to handle 
single atoms and build items of similar size. Since then, with 30 years of 
research and development, nanotechnology infiltrates almost every field of 
science and industry; from biology to building science, from electronic and 
environment control [5-8], and brings new promises and pushes the 
boundaries in each field. Still, due to its innate complexity and distance from 
everyday experience, the pervasive feeling is that we are just scratching on the 
surface.  
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Medicine is one of the most emblematic fields in which nanotechnology 
presents greatest opportunity but also vexing with difficulties. Human body is 
a perfect interacting system of cells, organelles, enzymes, proteins, nucleic 
acids and molecular signaling. On the other hand, nanomaterials are widely 
studied in biology because they are similar in composition (i.e. chemical, 
physical, structural, and topographical properties) to molecules and building 
blocks of many biological systems [9]. From these considerations, 
Nanomedicine represents a tool to interact with single components of our body 
[10]. The upcoming possibilities are probably matched only by the complexity 
of such a goal. Nowadays, the word Nanomedicine refers to application of 
nanoplatforms for specific roles, as drug delivery (with special regards to 
tumor sites) [11, 12], tissues regeneration [13], molecular detection and 
imaging diagnosis [14, 15], and direct treatment of illness [16-18]. Peculiarity 
of this field is the demand for a multi-disciplinary approach, regardless of the 
specific application of nanostructured devices.  
 
  
3 
 
 Introduction 
 
Figure 1-1. Nanodevice for cancer treatment. 
An ideal nanodevice designed for the cure of cancer should be able to perform 
in two phases: (i) recognize and selectively target the region of interest 
region(s); (ii) locally deploy one or more functions finalized to the cancer 
treatment. (Source: S.M. Sonal, V. Prabhakar, T. Aneesh, M. Sabitha; Int. J. 
Nanotech. 2008 Vol. 2 Num. 2) 
 
Hyperthermic treatments for malignant tissues 
The use of heat to treat various ailments, and cancer in particular, has 
roots that run deeps in the history of medicine [19]. First documented practices 
go back to the ancient Egyptians, over four thousand years ago; at that time, it 
was common practice to apply hot oil or cautery to tumors [20]. Later on, 
Hippocrates himself suggests that if a tumor “cannot be cut, it should burned. 
If it cannot be burned, then it is incurable.” [21, 22]. It is sadly surprising to 
consider how current this can be still today, for several cancers.  
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Heat affects the architecture of cellular cytoskeleton; the molecular 
transport across the cell membrane; and the function of receptors, in a dose 
and time-dependent manner. Several causes have been attributed for the 
variable sensitivity of cancer cells to high temperatures. Mainly, mutated or 
underexpressed heat shock proteins increase cells sensitivity to heat; on the 
other side, in few cases a deregulation of these macro-molecules brings to an 
increased resistance [23, 24]. Nevertheless, tumors are known for their dis-
organized and compact vasculature, which is inefficient in dissipating heat; 
consequently, a strong, localized hyperthermia treatment has been 
demonstrated to be most effective against the tumors [25-29]. The appropriate 
balance between temperature and duration is the key for a correct balance 
between the desired cancer cell death and undesirable normal cell toxicity. 
Several forms of hyperthermic treatments have been developed. Whole 
body hyperthermic therapy has been utilized by inducing an excessive overall 
heat production up to 42 °C for extended periods of time (few hours) [30-33]; 
the objective can be reached by injection of toxins to produce an hyperthermic 
reaction associated to unspecified immune response. Contact-based 
approaches see externally warming the patients by immersion in hot water or 
wax, or with high rate water perfusion blankets [34]. Other approaches for 
whole body hyperthermia uses extracorporeal circuit: the blood taken from the 
patient circulates into a heat exchanger and reenter the body providing high 
heating rate and essentially no toxicity [31, 35]. Less invasive methods 
employ electro-magnetic fields radiations ranging from radiofrequencies (RF), 
microwaves (MW), infrared (IR), visible light and even ultra-violet 
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frequencies; the absorption rates of the incident field is usually proportional to 
the square of the field strength, but the penetration depth depends on the 
frequency. RF spectrum ranges from 0.3 kHz up to 300 MHz, which 
correspond to wavelengths from 1’000 km to 1 m; for this reason, since able to 
penetrate the whole body without reducing power, RFs are widely used for 
radiation hyperthermia. 
Regional hyperthermia therapy usually involves intratumoral 
placement of an electrode able to increase local temperature as high as 100 °C. 
Hyperthermia is achieved when temperature in the cell is raised a few degrees 
above 42 °C [36] for prolonged time. Instead, ablation therapies are specific 
treatments that cause total burn/elimination of targeted cells and requires 
temperatures of 50 °C and higher [37, 38], usually for short periods of time. 
Effective hyperthermic cancer therapy can be induced by either long period 
hyperthermia, or short duration ablation; eventually, both the treatment can be 
applied at the same time. Mild hyperthermia is insufficient per se to induce 
significant cell death and, therefore, is mostly used as an adjuvant treatment in 
combination with conventional radiation- and chemo-therapy [39-41]. This 
takes the form of an isolated limb perfusion of chemotherapy warmed to 42 – 
45 °C for 1 hr or longer. 
The nanotechnology approach to hyperthermic treatments uses electro-
magnetic fields as external source of energy, and magnetic nanoparticles as 
receiver and local heat transducer. The remarkable advantages include high 
resolution of application, and reduced invasiveness for sites deep into the 
body. Already approved by the American Food and Drug Administration 
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Agency (FDA), some gold and iron oxides (IOs) nanoparticles are actually 
used in clinical practice for hyperthermic therapies. Gold based nanoparticles 
show their high potential in combination with nIR laser [42-47]; at the 
submicron size range, they show particular plasmon resonance at wavelengths 
of lights approximately between 650 and 950 nm. As results the absorbed 
optical energy produce remarkable increase in temperature. Unfortunately, a 
big limitation is the poor penetration deep due to the high attenuation of nIR 
waves by the biological tissues. Differently, IOs nanomaterials are excited 
using RF magnetic fields, which easily penetrate the whole human body 
without sensible attenuation. The processes underling the heating of IOs vary 
depending on the particles size, and are deeply treated in Chapter. 2. Above 
all, IOs were widely investigated in medicine for their versatility in several 
biomedical applications as Magnetic Resonance Imaging (MRI), and bone 
regeneration. 
To date, countless investigators devoted their efforts towards thermal 
treatments mediated by nanoparticles. The last decade saw many meaningful 
developments in all the aspects related to the scope, till the point that it took its 
steps from being a simple subsection of a more general field. Even if direct 
translatability requires further investigations on long term toxicology, 
recurring tumors, and metastasis, successful animal trials have been published 
reporting tumor full regression [48, 49]. Still, despite all these improvements, 
an efficient solution seems still far to be achieved.  
In this view, one of the main issues can be found in the lack of a most 
general, quantitative model to compare the different results achieved upon the 
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most different experimental conditions (field generator power, in-vitro setups, 
and in-vivo tumor models). This can indeed undermine a correct understanding 
of the results in the community and generate confusion. As a consequence, 
guidelines for the design of efficient hyperthermia and ablation treatments are 
still missing; risks related to this absence are loss of focus on what is actually 
still needed to achieve efficient treatments, and diminished efficiency in the 
researchers efforts. 
Also, all that “room at the bottom” is still far to be totally employed. 
Especially IOs particles offer huge opportunities for the construction of a 
multifunctional device, also operating as MRI imaging contrast agent [50-52] 
and drug delivery system [53], synergistically. These opportunities enlist 
within the many options already at reach today, but still waiting to be properly 
exploited. 
 
Therefore, the goal of this thesis work is the development of rationally 
designed nanotechnology for hyperthermic application. This goal is pursued 
by fulfilling three aims: i) the definition of the requirements for an efficient 
hyperthermia; consequently, ii) the definition of guidelines (design maps) for 
the hyperthermic treatment of tumors with superparamagnetic nanoparticles; 
finally iii) the enlargement of the optimal design of IOs nanodevices to 
perform at their full potential, merging hyperthermic performances with not 
heat-related capabilities. 
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1.1.1. Outline 
This dissertation is organized in a total of 5 Chapters, each of them 
closed with discussions on the results achieved. Chapter. 1 and Chapter. 5 
are, respectively the introduction and conclusion of this work, plus proposed 
future works based on our findings.  
Chapter. 2 presents the theoretical underpinnings of this work. The accepted 
theory [54] on power losses in superparamagnetic nanoparticles is run through 
from its basis; similar process is done for deduction of specific absorption rate 
(SAR). Considerations on parameters affecting this index and its validity as 
comparative model are discussed. Also, the mathematical model is further 
expanded to include temperature diffusion in-vivo. 
Chapter. 3 deals with systematic analyses of the key factors for rational 
design of an efficient thermal therapy, as an attempt to generate a proper 
comparative model and design guidelines. In-vitro experiments and in-silico 
simulations are reported and their results discussed. 
Chapter. 4 expounds on optimal design of systems based on 
superparamagnetic iron oxide (SPIO) particles, merging heating proprieties 
with other typical features of SPIOs never reported for the same system. It is 
developed the synthesis of a novel nanoconstruct, performing comparably with 
the best results in literature in heating, T2 relaxation time, and magnetic 
dragging. 
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 Theoretical model of heat generation and transport 
 Theoretical model of heat generation and 2.
transport 
Electric heating involves absorption of energy from a body exposed to an 
electro-magnetic field. A magnetic field is able to excite a magnetic particle 
which in turn develops a magnetization field. If the incident field is alternated, 
the induced magnetization follows the external field. An alternating magnetic 
field (AMF) ranging from 3·10
2
 - 3·10
8
 Hz (radiofrequencies) is particularly 
convenient for medical applications because it freely penetrates the human 
body and reaches the deepest sites. For biomedical applications, different 
heating mechanisms are involved depending on nanoparticle (NP) size. For 
example, heating of NPs smaller than 100 nm is associated with 
Neel/Brownian relaxation, or hysteresis loss [54]; whereas Joule heating is the 
dominant effect for larger iron oxides (IOs). Hysteresis is generated by 
alternating magnetization of a multi-domain body, and hysteresis loss 
dominates for nanoparticles with a larger magnetic core (20 – 100 nm) [55]. 
Structural imperfections and impurities in the particle structure introduce 
irregularities which accumulate in singular points for the inner magnetic field 
within the volume. These discontinuities resolve forming magnetic boundaries 
between regions (Weiss domains) with different dipoles [56]. These generate 
coercivity and the total magnetization of the particles does not grow linearly 
with the external field; As a result, in alternating fields the reversal 
magnetization is also delayed, forming a loop in the magnetization versus 
applied field graph.  
  
10 
 
 Antonio Cervadoro 
Superparamagnetism arises for particles small enough to not possess 
magnetic domain. Their inner dipole hence freely rotates within the applied 
field. In this chapter, the accepted theory [54] on power losses in 
superparamagnetic nanoparticles is reviewed starting from the first law of 
thermodynamics. From the same principle, with specific application to in-vitro 
experiments later described (Chapter. 4); the definition of specific absorption 
rate (SAR) is deducted. Still, the boundary conditions are such that the results 
are still valid for general purpose. The mathematical model is further 
expounded on to include temperature diffusion in-vivo, following Pennes’ 
equations and their revision [57, 58]. This model is used to generate a 
simulation code whose results are reported in Chapter 3. Finally, 
considerations on SAR s validity as comparative model are also discussed 
along with analysis of several parameters that influence it and, in the 
prospective of a proper design for both particles structure and field generator. 
 
 Magnetic loss power in radiofrequency 2.1. 
regime 
A superparamagnetic NP exposed to a radiofrequency (RF) alternate 
magnetic field (AMF) is subject to heating due to power dissipated from 
dipole relaxation. The mathematical model depicting the heat produced has 
been well defined by Rosensweig [54], who calculated the dissipated power 
per unit volume P of a colloidal suspension of NPs. Starting from the first law 
of thermodynamics applied to a constant density system: 
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QWdU    [J m
-3
] (2-1) 
Considering an adiabatic process (i.e. 0Q ), the only contribution to the 
internal energy is provided by the magnetic work done on the particle: 
BdHWdU

   [J m
-3
] (2-2) 
here  ⃗  and  ⃗  are the magnetic field and its induction inside the particle, 
respectively. The fields are collinear to each other, thus the relationship is 
reduced to the simple product of their magnitude. The induction B is given by  
HMHB )1()(
00
   
HM   
[T] 
[A m
-1
] 
(2-3) 
where magnetization M of particles is related to its magnetic susceptibility χ; 
0
 is the magnetic permeability in the vacuum. Integration by parts leads to:  
 dHMW 0  [J m
-3
] (2-4) 
We can reduce the magnetization in an in-phase and an out-of-phase 
component into:  
]Re[cos)(
00
ti
eHtHtH

   
)sincos(]Re[)(
00
ttHeHtM
ti


  
[A m
-1
] (2-5) 
and the integral becomes:  
UHdttHW   

2
00
2
0
22
00
sin  [J m
-3
] (2-6) 
This relationship shows that the only remaining factor responsible for energy 
variation in particle volume is the out-of-phase component of magnetic 
susceptibility, which take the name of “loss factor”. This loss factor relates the 
power dissipation to the intrinsic particle magnetic properties and therefore is 
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associated with its specific magnetization and relaxation times. Following the 
lead of Shliomis [59], Rosensweig reports the relaxation equations for static 
fluid subject to AMFs as:  

))()(()(
0
tMtM
t
tM 



 [A m
-1 
s
-1
] (2-7) 
20
)2(1
2
''



f
f

  [a.u.] (2-8) 
0
 is a constant more accurately defined in the following.  
The final power lost per unit of volume is obtained multiplying for the field 
frequency f:  
20
2
00
2
00
)2(1
2



f
f
HfHfUfP

  [W m
-3
] (2-9) 
 
 
2.1.1. Magnetic equilibrium susceptibility 
0
  actually also depends on the incident field. A conservative 
estimation approximates its value to the “chord” susceptibility associated with 
a Langevin function:  













1
coth
3
)(
0 ii
S
i
L
M
M
 [a.u.] 
(2-10) 
TkHVM
BMD
/
0
   [a.u.] 
DS
MM   [A m
-1
]  
fM
VV  [a.u.] 
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where: MD and VM are the domain magnetization and the magnetic volume of a 
suspended NP, respectively; kB is the Boltzmann’s constant; T the temperature. 
  defines the volume fraction of the particles dispersed in the solution with 
total volume Vf, and is an fundamental scaling factor for the proper design of 
hyperthermia treatment; further discussion about is remanded to section 2.3.1 
and 3.3.6 MS is the magnetization saturation of the whole colloidal suspension. 
i
  is derived as the initial susceptibility directly from the Langevin equation 
as:  
  TkVMHM
BMDii
3/
2
0
   [a.u.] (2-11) 
Recently, Jánosfalvi et Al. [60] proposed that this approximation is reliable 
only for the typical low field ranges used for hyperthermia treatments. Based 
on their calculation, the chord susceptibility results in a negligible 
underestimation of the effective power losses for H0 < 30 kA m
-1
. Here the 
difference is calculated to be ~8 %, and it reach the 20% for H0 = 100 kA m
-1
. 
 
2.1.2. Neel and Brown relaxation times 
A particle exposed to AMFs rotates in line with applied field; the time 
required to complete this movement is called relaxation time. Two possible 
rotations can occur for a free particle without restrictions: (i) Neél relaxation 
of the inner dipole of the particle [61] and (ii) Brown relaxation of the whole 
particle inside the immersed medium (Figure 2-1). The effective relaxation 
time is dominated by the faster of the two:  
 
1
1
B
1
N


   [s] (2-12) 
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Neél relaxation time is based on the ratio between the magnetization 
energy of the particle and its thermal energy. In this model, the contribution of 
magnetization energy is provided by a single anisotropy constant K, and a 
correct estimation of this value has been demonstrated to be highly effective 
on the objective of an efficient hyperthermia treatment [62, 63] (see paragraph 
2.5). 
Tk/KV
)Tk/KVexp(
2
BM
BM
0N


   [s] (2-13) 
τ0 is an average relaxation time, ~10
-9 
sec for IOs. 
Brown relaxation occurs for particles in a wet environment. It takes 
into account whole particle rotation and the friction from medium viscosity η. 
The time elapsed between each leap is defined by the ratio between the 
viscosity and the thermal energy multiplied by hydrodynamic volume of the 
particle, VH: 
Tk
V3
B
H
B

   [s] (2-14) 
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Figure 2-1. Neél and Brown relaxation modes. 
The inner dipole of a superparamagnetic particle following an external 
magnetic field is subjected to two rotation modes. During Neél relaxation, the 
particle actual body remains still and the dipole rotates according to the 
external field. Instead, the Brown relaxation includes also the particles body 
alongside with the magnetic dipole. 
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 Heat transport modeling 2.2. 
Application of Equation (2-9) for experimental quantifications of 
particles performances requires a further step in modeling of heat exchanges 
between the colloidal fluid and its surrounding. The experimental setups are 
shown in detail in section 3.3.1. Briefly, a solution of nanoparticles (typically 
magnetite, Fe3O4) with known iron concentration is positioned at the 
geometrical center of a magnetic coil; a typical volume of ~600 µl of solution 
is stored in a tube and placed on a foam holder, which provides a first thermal 
insulation. The coil is hooked to an alternating current in RF regime and 
develops an AMF with tunable strength up to 10 kA m
-1
; at the same time, a 
constant flow of refrigerated water within the coil keeps its temperature 
constant ~19.8 °C and functions as heat sink. The system is represented in 
Figure 2-2. 
 
2.2.1. Application of first law of thermodynamics 
For the system mentioned above it is convenient to apply the first law 
of thermodynamics in its formulation for fluids in flow, this time for non-
adiabatic conditions: 




....
)(
vc
ff
sc
dVu
t
dSnvu
dt
W
dt
Q

 
 [W] (2-15) 
which imposes energy conservation between the instantaneous heat 
dt
Q
 added 
to the volume unit and its instantaneous work 
dt
W
 done on the environment. 
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The terms on the right are the net rate of energy transport out of the control 
volume (with fluid velocity   ) across its surface S, and the rate of 
accumulation of total energy within the control volume V. The sole 
contribution to the total energy is the specific internal energy u of the fluid 
since potential energy is negligible and the kinetic energy does not apply for 
fluid not in motion. Similarly, the first of the right-hand terms of Equation 
(2-15) equals zero; ρf represents the fluid density. 
The heat rate provided by the magnetic loss is independent from other 
heat exchanges q that may occur at the interface between the liquid and the 
surrounding; hence Rosensweig’s results are still valid:  
q
dt
Q


 
f
PV
dt
W


 
[W] (2-16) 
The pedix f denotes the whole fluid. As for the second right-hand term in 
Equation (2-15), considering the total variation on internal energy dU, it can 
be written as:  
dVp
T
p
TdTCdU
V
V 













  [J] (2-17) 
where: CV is the heat capacity at constant volume; p is the pressure; 
V
T
p








is 
the partial derivative of the pressure with respect to the temperature at constant 
volume; dT and dV define the total variation in temperature and volume, 
respectively. The latter is considered dV ≈ 0 since the fluid volume change is 
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assumed negligible. Rewriting the equation in specific formulations and 
solving, the integral results in:  
ffpf
V
dt
dT
cqPV   [W] (2-18) 
with cp being the specific heat conductivity at constant pressure. 
 
2.2.2. Heat transport and sample tube geometry 
Instantaneous heat exchanges q can be calculated based on convective 
and conductive thermal transfers between the heat sources in the fluid to the 
heat sink represented by the coil. The axial center of the vial is defined as the 
effective fluid temperature Tf(t), and the coil at constant temperature Ta. 
The cylindrical geometry is represented in Figure 2-2. It consists of three 
sections: (i) the cylindrical main body of the tube, with height L and radius re, 
surrounded by air; (ii) a first truncated cone, with height H, larger radius re, 
and smaller radius r1, surrounded by air; (iii) a second truncated cone having 
height J, larger radius r1, and smaller radius r2, inside an annulus truncated 
cone section of polystyrene, larger radius r1+x and smaller radius r2+x. For 
sake of simplicity, the tube walls are approximated to have infinitesimal 
width. The temperature of the fluid is monitored using an optical probe 
positioned at the center of the tube.  
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Figure 2-2. Modeling of heat transport through a vial. 
The Eppendorf tube used for in-vitro characterization has been modeled with a 
3-parts geometry. The first is a cylindrical section defined by height L and 
radius re. The second section is reverted truncated cone, height H, larger radius 
re, smaller radius r1. The third part is a second, smaller truncated cone, height 
J, larger radius r1, smaller radius r2; this last section is surrounded by an 
annulus truncated cone section of polystyrene which model the tube holder; its 
height is defined as J, the larger radius is r1+x and the smaller radius r2+x. 
The inner of the tube contains the colloidal suspension of nanoparticles with 
temperature Tf. The temperature wall, approximated to have infinitesimal 
width has temperature Te. Apart for the third section, the outside of the tube is 
considered as air up to a distance r2+x from the center; where the presence of 
the magnetic coil is modeled as a heat sink with constant temperature Ta. 
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Total volume of the fluid is 
))((
3
1 2
2
22
rrHJLrV
eef
   [m
3
] (2-19) 
and the instantaneous heat transfers formulas applied to this geometry are 









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
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)(,)()()(
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21
2
21
2
21
2
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iiiTTrrJrrh
iiTTrrHrrh
iTTLrh
ThAq
e



 [W] (2-20) 
for convection heating; where A refers to the exchanging surface, and h 
indicates the exchange coefficient. For conductive heating through the annulus 
in the third section we have: 
)(,)(
)ln()2ln(
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 [W] (2-21) 
Replacing the proper parameters for each section:  
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[W] (2-22) 
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where ha and hf are heat exchange coefficients for air and fluid, respectively; k 
is the thermal conductivity for the polystyrene holder; and Te is the tube 
temperature at the wall. The final formulation is obtained imposing heat flux 
continuity and summing each contribution:  






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
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
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
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
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

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R
TT
RRR
RRRRRR
TTqq
af
afi



 
321
213132
)(  [W] (2-24) 
where R indicates the thermal resistance between fluid and ambient. 
 
2.2.3. Determining the temperature-time relationship 
Equation (2-18) now becomes 
f
f
fp
af
f
V
dt
tdT
c
R
TtT
PV
)()(


  [W] (2-25) 
or 
dt
tdT
RVc
TtT
c
P f
ffp
af
fp
)()(




 [K s
-1
] (2-26) 
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P is actually temperature dependent. In the interest of this study, it is 
convenient to consider the nanoparticle power dissipation as constant within 
the typical range of temperature used in hyperthermia applications. 
Defining:  
fp
cPB   [K s
-1
] 
(2-27) 
ffp
RVc
A

1
  [s
-1
] 
Equation (2-26) is rewritten as:  
AtTATB
dt
tdT
fa
f
)(
)(
   [K s
-1
] (2-28) 
which solution is 
a
At
f
T
A
B
eCtT 

1
)(   [K] (2-29) 
The boundary condition is provided by the equilibrium temperature reached 
before turning on the AMF and thus:  
af
TT )0(  
A
B
CT
A
B
CT
aa

11
 
[K] (2-30) 
Finally, the close formulation of temperature increase is: 











1)1()(
ffp
RVc
t
fa
At
af
ePRVTe
A
B
TtT

 [K] (2-31) 
In this formula the roles of each component that affect the temperature curve 
are clear: the term B contains the source of heating and is responsible for the 
initial temperature increment. The factor A is defined to include the 
  
23 
 
 Theoretical model of heat generation and transport 
geometrical conditions and heat exchange terms, which dampens the 
temperature increment towards a new equilibrium. Finally, their ratio 
represents the total temperature variation. These are depicted in Figure 2-3. 
It is important to note this is a general formula. Due to the decoupling 
between the heat source and the heat exchange terms, it is possible to 
independently identify these two contributions starting from the temperature 
measurement of any object with a homogenous heat transport. It is worth to be 
noted that correct separation between these two contributions is only possible 
thanks to the choice of the condition in Equation (2-30), which requires the 
experiment is conducted starting form equilibrium conditions. 
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Figure 2-3. Graphical representation of the terms A and B in Equation 
(2-31). 
It can be appreciated the decoupling of heating source, associated with B, and 
the heat exchanges contained in A. Also, these two factors indicate for the total 
temperature variation. B is connected to the particles dissipated power by the 
initial slope of the temperature profile and is independent from the single 
experiment; A is responsible for the establishment of new equilibrium and is 
determined by experimental conditions. Plotted triangles identify measured 
data points, and the solid line is the curve interpolated by Equation (2-31). 
Temperature profile is obtained by 14 nm magnetite spherical particles, 
concentration of 0.23 mg ml
-1
, excited by a 4 kA m
-1
 – 30 MHz AMF. 
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 Definition of specific absorption rate 2.3. 
Outcome from in-vitro experiments as mentioned above are the fluid 
temperature excursion Tf(t). From this, two main results can be obtained: the 
maximum rise in temperature T, and the power losses. For the final goal of 
an efficient in-vivo hyperthermia, T is the utmost important reference since 
quantifies the heat provided with the treatment. Unfortunately, T strictly 
depends on specific experimental conditions; it takes into accounts the 
geometry of experimental setup, NPs employed, their concentration, and/or the 
blood perfusion. For this reason, it is inadequate to define the quality of the 
treatment but, more importantly, cannot be applied for the comparison of 
different methodologies. Differently, the specific absorption rate (SAR) is 
commonly used in literature to quantify the efficiency of a body to convert 
magnetic energy in heat. 
 
2.3.1. SARf and SARNP 
Equation (2-25) can be rewritten to highlight the work done per unit 
of mass:  
f
f
fp
af
f
V
dt
tdT
c
R
TtT
PV
)()(


  [W] (2-25) 
dt
tdT
c
RV
TtTP f
p
ff
af
f
)()(




 [W kg
-1
] (2-32) 
The second term on the left hand side defines the heat transfers towards the 
environment. Looking at the very first moments after the magnetic field is 
turned on, for t = 0, Tf (0) = Ta and there are no exchanges: 
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fp
t
f
f
SARc
t
TP




 0

 [W kg
-1
] (2-33) 
This result defines a contribution to the heating which is time-independent, 
identified by the initial, linear region of the exponential function in Equation 
(2-31). Therefore, the correct computing of the NPs contribution to heating is 
only possible for Tf (0) = Ta, which justify the previous choice of Equation 
(2-30). Equation (2-33) provides two methods for estimation of the whole 
fluid SARf: a computational calculation based on Rosensweig equation, and an 
empirical measurement based on Tf (t). 
Still, our objective is not the heating efficiency of the fluid, rather the 
quality of the NPs in solution. From Equations (2-10) and (2-11), the power 
loss for volume unit of fluid P is directly proportional to the volume fraction
; hence, a similar normalization can be obtained by dividing both terms of 
Equation (2-33) by the mass fraction mNP  
fNP
ff
NPNP
MNP
V
V
m 


  [a.u.] (2-34) 
NP
NP
p
t
f
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m
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t
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



 0

 [W kg
-1
] (2-35) 
Where 

P
P
NP
  is the loss power per unit volume of nanoparticle; similarly, 
SARNP represents the definition of SAR of the magnetic nanoparticles alone. 
Note that SARNP does not depend on the NPs concentration but solely on PNP 
and their density.  
SARNP is commonly referred in the literature simply as SAR. Therefore, in the 
following, the same notation will be adopted, if not otherwise indicated 
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 Finite element modeling of the temperature 2.4. 
field 
In collaboration with the group of Prof. Luigi Preziosi from the Dept. of 
Mathematical Science at the Polytechnic of Turin, we used the Pennes’ bio-
heat equations [64] to quantify the temperature field within a domain of 
interest. The defined model describes the heat transfer phenomena in 
biological tissues, accounting for both healthy and neoplastic ones. The 
contributions in the temperature increase include: i) the specific heat provided 
by magnetic nanoparticles uniformly distributed, and ii) the non-specific heat 
due to salts dispersed in the physiological fluids. Similarly, blood perfusion of 
the tissue is modeled as a distributed heat sink within the computational 
domain. This is a square composed of two areas: a central region representing 
the tumor where magnetic nanoparticles could be laid uniformly (2), and an 
outer region representing the surrounding healthy tissue (1). The whole 
region is permeated by blood vessels, such that the heat exchange of the 
healthy tissue with these is also extended to the region 2 as described in [65].  
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Figure 2-4. Domain of interest for the modeling of temperature field.  
The region of interest is composed by a 10 mm x 10 mm square for a total of 
3816 triangular elements. The outer region Ω1 corresponds to healthy tissue; 
the sole heating here is generating by the non-specific contribution of salts 
dispersed in physiological tissues; the inner region Ω2 corresponds to the 
tumor area, which contains both specific and non-specific heating sources. 
Temperature diffusion in the whole area is simulated for different particles 
concentrations and perfusion rates. 
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The equations describing the temperature evolution within the domain 
are the following 
   
1bl1,blblbl111
QTTwcTk
t
T
c 


  , in 
1
  [W mm
-1
] (2-36) 
   
2bl2,blblbl222
QTTwcTk
t
T
c 


  , in 
2
  [W mm
-1
] (2-37) 
   0T  on in  [K] (2-38) 
    nTknTk


21
 on in  [W mm
-2
] (2-39) 
   
blv
TThnTk 

1
 on 
ext
  [W mm
-2
] (2-40) 
  CtT  370  in Ω1 Ω2 [°C] (2-41) 
where Qi [W mm
-1
] is the heat power density generated inside the region i; 
ki, ρi and ci are respectively the thermal conductivity [W mm
-1
 K
-1
], the density 
[kg mm
-1
] and specific heat capacity [J kg
-1
 K
-1
] of the domain under 
consideration, i, with i = 1,2. All of the terms in 2 are defined according to 
the mixture theory [66, 67] for porous continua, it follows 
  
NP
 1
12
,   
NP
ccc  1
12
, and   
NP
kkk  1
12
. The 
perfusion parameters 
1,bl
w  and 
2,bl
w are the tissue perfusion rates (s
-1
) in 1 
and 2 respectively, which have the following explicit expression, following a 
modified version of the model presented in [68, 69],  
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where R is the universal gas constant; A is the frequency factor; ΔE is the 
activation energy; 0
1,bl
w  and 0
2,bl
w  are the baseline perfusion values for the 
tissue. Table 2-1 lists all the numerical values used during the computations. 
Whilst in Ω1 the non-specific heating given by the salts dispersed in the 
physiological fluids is the sole source of heat, in Ω2 is also considered the 
specific contribution from the magnetic NPs. Therefore, it follows 
NaClNaClNaClNaClNaCl
SARPQ  
1
 [W mm
-1
] (2-44) 
ffNP
NaClNaClNaClNPNaClNaCl
SARSAR
SARPPQ




2
 [W mm
-1
] (2-45) 
The system of Equation (2-36) – (2-45) is solved using the finite element 
software (FEM) Comsol
®
 (version 3.5a), with direct UMFPACK linear system 
solver. During calculations, relative and absolute tolerances are fixed to 0.01 
and 0.001, respectively. The computational mesh consists of 3816 triangular 
elements, simulating a 2D square domain of 10 mm side. 
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Parameter Description Value Ref. 
Tbl Blood temperature 273.15 + 37 K Known 
𝛒bl Blood density 1.06·10
-6
 kg mm
-3
 [70] 
𝛒1 Tissue density 1.06·10
-6
 kg mm
-3
 [69] 
cbl 
Blood specific heat 
capacity 
3.59·10
3 
J kg
-1
 K
-1
 [71] 
c1 
Tissue specific heat 
capacity 
3.47·10
3
 J kg
-1
 K
-1
 [72] 
k1 
Tissue thermal 
conductivity 
0.51·10
-3 
W mm
-1
 K
-1
 [69] 
A Frequency factor 1.98·10
6
 s
-1
 [69, 73] 
𝚫E Activation energy 6.67·105 J mol-1 [69, 73] 
R 
Universal gas 
constant 
8.314 J mol K
-1
 Known 
SARNaCl Tissue SAR 450 W kg
-1
 From experiments 
SAR Tissue + NPs SAR 900 W kg
-1
 From experiments 
hv 
Heat exchange 
coefficient 
1.65·10
-3
 W mm
-2
 K
-1
 
From exp., and in 
the range of [74] 
Table 2-1. Parameters used in finite element simulations. 
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 Discussion on SAR limitation as evaluating 2.5. 
parameter 
Looking at Equation (2-9), it can be noted that the effects on heating for 
an exposed particle to RF fields is composed of two main contributes. A first 
component is solely dependent on the applied field (H0, f); a second 
component is primarily dependent on the particle properties (d, K, Ms), and 
only in given limits on the field. It must be here considered that, as for 
Equations (2-10) the chord susceptibility χ0 also depends on the field strength 
H0 for each given particle diameter d and saturation magnetization Ms: 
 ),,(),,(
00
2
0
fKdHMdfHSAR
S
  [W kg
-1
] (2-46) 
With 
2
)),(2(1
),(2
),,(
Kdf
Kdf
fKd



 . 
In order to effectively quantify how the variation in the field strength can 
be reverted on the chord susceptibility, it is useful to identify its maximum 
sensitivity over H0. A sensitivity function 
f
x
x
f
S
i
i
f
x
i


  quantifies the variation 
that a study function f(xi, xii, xiii,…) undergoes, compared to the variation of 
the parameter xi of interest. A null sensitivity function indicates independence 
from the parameter; whereas a value of 1 indicates a variation of f in the same 
entity of the variation for xi.  
The close computation of 0
0

H
S  as function of both particle diameter and 
saturation magnetization is not trivial, but for the scope of this work, a 
numerical resolution can be considered sufficient. Figure 2-5A plots the 
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values 0
0

H
S  assumes for ranges of d and Ms typically found in biomedical 
applications. At 100 emu g
-1
, the figure shows values identically equal to zero 
only for small particles (≤ 5 nm) diameter; then, the sensitivity functions 
quickly decreases to reach a minimum of -1 for diameters larger than 20 nm 
and field strengths higher than 10 kA m
-1
. Improved magnetization saturation 
(e.g. 200 emu g
-1
) shifts the decreasing curve towards smaller particles (≤ 2 
nm); whereas for an Ms of ~20 emu g
-1
, 0
0

H
S  is calculated to rest on zero up to 
10 nm and then decreases till it reaches the value of -1 for diameter greater 
than 22 nm and field strengths higher than 45 kAm
-1
. 
A similar approach can be used to evaluate the dependence of the 
factor 
2
)2(1
2


f
f

  from the applied frequency. Figure 2-5B plots the 
function 
f
S  calculated for d up to 30 nm and an anisotropy constant K 
ranging between 3 and 300 kJ m
-3
; this range covers one order of magnitude 
above and below the bulk value for magnetite (Fe3O4) and maghemite (γ-
Fe2O3) crystals. In these ranges, the sensitivity function 

f
S  is negligibly 
dependent on the frequency. Instead, its calculated values abruptly drop from 
1 to -1 as soon as the nanoparticle size increases over the resonance diameter, 
which is characteristic for each given crystalline energy value of the material. 
This resonance diameter shifts from ~25 nm at 3 kJ m
-3
 to ~6 nm at 300 kJ m
-
3
.  
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Figure 2-5. Sensitivity analysis of the imaginary susceptibility χ”. 
The imaginary susceptibility is divided in its two components χ0 and 
2
)2(1
2


f
f

 . In panel (A) the sensitivity 0
0

H
S  is calculated for field 
strength H0 ranging from 0 to 60 kA m
-1
, particle diameter up to 30 nm, and 
saturation magnetization Ms varying from 20 to 180 emu g
-1
. Panel (B) shows 
the sensitivity 

f
S  calculated for frequencies f = 0.1÷1 MHz, diameter d = 
0÷60 nm, and crystalline anisotropy K = 3-300 kJ m
-3
. For both χ0 and Φ the 
maximum sensitivity (over H0 and f) never exceeds the value of ±1. This 
indicates, at the most, linear proportionality between the variations of the 
functions and these parameters, respectively. The simulations consider 
conditions ranges that widely include typical biomedical applications.  
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Based on the relationship (2-46), some authors suggested the use of a 
derived, more specific index [75, 76] in the attempt to have a system-
independent parameter, called intrinsic loss power (ILP): 
  
0
02
0
/ 


fHSARILP  [(m
2
 s
1 
A
-1
)
2
] (2-47) 
Such normalization would bring an intrinsic uncertainty in the effective 
particle efficiency, which will fall between 0.25 % and 200 % of the so 
calculated value. Several considerations may be taken to highly reduce this 
range of possibilities and calculate a more efficient index to compare the 
heating quality of particles characterized under different magnetic fields. Such 
calculations would deserve proper discussions and deep–in considerations in a 
separate form; for the sake of simplicity ILP will be considered as 
approximated in Equation (2-47) in the following work; this will not 
eventually undermine the drawn conclusions. 
In conclusion, ILP could be less intuitive but, as far the heating process 
is related to superparamagnetic behaviors, it provides a better instrument to 
compare, in first approximation, results from different works and experimental 
system. In Table 2-2 are reported a series of SAR values from literature, 
compared with the calculated ILP. Still, SAR remains the main index used in 
literature to evaluate the quality of achieved results.  
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# Reference Material Diameter fH2 SAR ILP 
   [nm] [A
2 
m
-2
 s
-1
] [W kg
-1
] [(m
2
 s
-1 
A
-1
)
2
] 
1 [77] γ-Fe2O3 5.3 4.3·10
14
 4.0·10
3
 9.0·10
-12
 
2 [77] γ-Fe2O3 6.7 4.3·10
14
 1.4·10
4
 3.3·10
-11
 
3 [78] γ-Fe2O3 9 4.3·10
13
 1.8·10
3
 4.1·10
-11
 
4 [78] γ-Fe2O3 25 4.3·10
13
 2.5·10
3
 5.9·10
-11
 
5 [77] γ-Fe2O3 8 4.3·10
14
 3.7·10
4
 8.6·10
-11
 
6 [79] γ-Fe2O3 10.9 8.0·10
11
 2.0·10
2
 2.5·10
-10
 
7 [79] γ-Fe2O3 10.9 1.2·10
12
 3.8·10
2
 3.1·10
-10
 
8 [79] γ-Fe2O3 10.9 1.0·10
12
 5.2·10
2
 5.3·10
-10
 
9 [79] γ-Fe2O3 10.9 9.0·10
11
 5.0·10
2
 5.5·10
-10
 
10 [77] γ-Fe2O3 10.2 4.3·10
14
 2.8·10
5
 6.4·10
-10
 
11 [77] γ-Fe2O3 16.5 4.3·10
14
 1.7·10
6
 3.8·10
-9
 
12 [80] 
Zn0.4Co0.6Fe2O4@ 
Zn0.4Mn0.6Fe2O4 
15 7.0·10
14
 3.9·10
6
 5.6·10
-9
 
13 [80] 
MnFe2O4@ 
CoFe2O4 
15 7.0·10
14
 3.0·10
6
 4.4·10
-9
 
14 [62] MnFe2O4   15 7.0·10
14
 4.4·10
5
 6.3·10
-10
 
15 [81] 
Fe3O4:Fe2O3 
 in 3:2 ratio 
13 3.1·10
12
 1.6·10
4
 5.2·10
-9
 
16 [62] Fe3O4 9 7.0·10
14
 1.5·10
5
 2.2·10
-10
 
17 [62] Fe3O4 15 7.0·10
14
 3.3·10
5
 4.8·10
-10
 
18 [62] Fe3O4 12 7.0·10
14
 3.5·10
5
 5.0·10
-10
 
19 [82] Fe3O4 8 5.7·10
13
 5.3·10
4
 9.2·10
-10
 
20 [82] Fe3O4 8 9.2·10
12
 1.7·10
4
 1.9·10
-9
 
21 [75] Fe3O4 12.5 6.1·10
12
 2.2·10
4
 3.6·10
-9
 
22 [75] Fe3O4 15.7 6.1·10
12
 2.8·10
4
 4.6·10
-9
 
23 [62] Fe2O4@CoFe2O4 15 7.0·10
14
 2.8·10
6
 4.0·10
-9
 
24 [62] 
CoFe2O4@ 
MnFe2O4 
15 7.0·10
14
 2.3·10
6
 3.3·10
-9
 
25 [62] CoFe2O4@ Fe2O4 15 7.0·10
14
 1.1·10
6
 1.6·10
-9
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26 [77] Co-Fe2O4 3.9 4.3·10
14
 4.0·10
2
 9.3·10
-11
 
27 [62] Co-Fe2O4 9 7.0·10
14
 1.0·10
5
 1.4·10
-10
 
28 [77] Co-Fe2O4 9.1 4.3·10
14
 3.6·10
5
 8.4·10
-10
 
29 [83] 
Bionized 
nanoferrite 
28 1.1·10
15
 2.1·10
5
 1.9·10
-10
 
30 [83] 
Bionized 
nanoferrite 
28 1.1·10
15
 5.4·10
5
 4.9·10
-10
 
Table 2-2. Published SAR and calculated equivalent ILP. 
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The same values presented in Table 2-2 are also reported in Figure 
2-6 for a more descriptive, figurative comparison. Evaluation of particle 
quality based on ILP leads, in some cases (e.g. samples 15, 23), to a totally 
different estimation of its thermal efficiency, if compared to the corresponding 
SAR. As matter of fact, in the overall view samples potentially underestimated 
are actually strongly penalized by low power fields used during the 
investigation. The bars in Figure 2-6 suggest that the same nanoconstructs 
would behave comparable to the best performing results reported in literature, 
if operated in similar conditions. 
 
Figure 2-6. Comparison Specific Absorption Rate (SAR) vs. 
corresponding Intrinsic Loss Power (ILP). 
Based on the linear dependency of SAR on the product H0
2
·f, the 
corresponding ILP is calculated and compared for different results in 
literature. The ILP provide and index to quantitatively evaluate the heating 
potential of a nanoparticle formulation independently from the incident 
magnetic field.  
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This decoupling between particle capabilities and field power is most 
convenient because it allows for separated designs of the applied field and the 
nanoparticle formulations. As for the applied field, since it is disconnected by 
the heating efficiency of the particles, it can be devoted to separate needs, as 
patient safety or integration with different applications; both these aspects are 
further discussed in Chapter. 3 and Chapter. 4, respectively. As for the 
design of a most suited nanoconstruct, they should instead be taken in account 
the magnetic properties and the size. Again, following the work of 
Rosensweig, the magnetic properties of particles, are totally characterized by 
the anisotropy constant K, and magnetization saturation Ms; (Equations (2-8), 
(2-10), (2-11), and (2-13)). It can also be noted that the role of these two 
parameters are independent. Significant research in this direction has been 
published by Cheon and co-workers [62]. The contributions of the suspending 
media and the hydrodynamic volume of the nanoconstruct are instead 
accounted for in calculation of relaxation times. Figure 2-7 reports examples 
of calculated ILP over a wide range of diameter, K, and Ms but fixed magnetic 
field. An optimal particle size for each operating frequency f can be identified 
that would maximize SAR, as shown in Figure 2-7A for f = 500 kHz and H0 = 
10 kA m
-1
. The two contributions of Brownian and Neel relaxation are also 
clearly presented. This is addressed in the plots of Figure 2-7B and C, 
respectively and demonstrates that the maximum ILP grows as the anisotropy 
constant decreases and the magnetization saturation increases. Moreover, 
experiments have demonstrated that the heating efficiency of magnetic 
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nanoparticles can be enhanced by proper design of their surfaces [62, 83], 
shape and composition selection [62, 63]. 
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Figure 2-7. ILP dependence on saturation magnetization Ms and 
anisotropy constant K for f = 500 kHz, H0 = 10 kA m
-1
. 
Simulations on ILP dependence on the main parameters characterizing a 
superparamagnetic particle: (A) Neél / Brown relaxation times, (B) Ms; (C) K. 
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 Design maps for local hyperthermia and 3.
ablation therapy 
The hyperthermic treatment of a malignant tissue is based on the 
application of sufficiently high heat doses over time to induce cell death or 
cell sensitization [84, 85]. Most of the in-vitro studies based on nanoparticle 
(NP) for hyperthermic application are focused on maximizing the specific 
absorption rate (SAR), an index commonly used as sole parameter to quantify 
and compare the particle efficiency in converting electromagnetic energy into 
heat [51, 52, 76, 77, 80, 86, 87]. However, as extensively documented in 
section 2.5, SAR is not an intrinsic property of the NPs. As a result, very 
different SAR values have been published, ranging from 10
3
 to 10
6
 W kg
-1
, 
depending on the operating conditions (H0 = 1 – 100 kA m
-1
 and f = 100 kHz – 
50 MHz). On the other hand, in-vivo studies mostly investigate tumor 
regression over time, upon single or multiple hyperthermic treatments [88-90]. 
The tumor regression, similar to the SAR, is able to show the efficiency of a 
specific treatment but has little use as general comparative parameter. This 
creates confusion amongst the scientific community making the development 
of an efficient treatment more difficult. 
In conclusion, the question about what indications to follow on the design 
of efficient thermal therapies still remains unanswered. An efficient design 
should require: more comprehensive indexes that correctly evaluates the 
nanoplatforms employed in relation to the applied field; synergistic potential 
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with coadjutant treatments; unwanted effects; and can be tailored to take into 
considerations the eventual tumor- and/or patient-specific variability. 
This third chapter deals with the systematic analyses of key factors for 
rational design of an efficient thermal therapy. In-vitro experiments and in-
silico simulations were conducted in order to generate a proper comparative 
model and design guideline. The effects on the particles and tumor final 
temperature were estimated: for particle size, their concentration and magnetic 
properties; for the conditions of applied magnetic field; and for blood 
perfusion level. The contribution of non-specific heating over the specific iron 
oxide-induced heating is systematically analyzed at high- and low-frequency 
fields in reproducing physiologically relevant conditions. Clinically relevant 
strategies for improving the delivery of NPs within the tumor mass are then 
briefly discussed. 
Although several types of magnetic NPs have been proposed, magnetite 
(Fe3O4) is the most extensively tested material in clinically relevant settings, 
demonstrating favorable biocompatibility and biodegradability [91, 92]. 
Protocols are available for large scale production of biocompatible magnetite 
NPs and for their surface modification. For these reasons, Fe3O4 nanoparticles 
are the sole superparamagnetic iron oxides (SPIOs) considered in this work. 
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 SPIOs: characterization and processing 3.1. 
Commercially available SPIOs 
Several colloidal formulations of Magnetite (Fe3O4) iron oxides (IOs) 
are commercially available. For these studies, we purchased particles with a 
nominal magnetic core diameter of 5, 10, and 14 nm from Sigma-Aldrich (5 
and 10 nm) and Genovis AB (14 nm). A thin PEG (polyethylene glycol) layer 
coats these nanoparticles and provides sufficient hydrophilicity. Samples 
provided by the manufactures needed purification process to remove 
aggregates and then the iron concentration was also measured.  
Sample purification 
Through a cycle of sonications, centrifugation, collection of 
supernatant and pellet re-dilution, the sample can be efficiently divided 
between two colloidal solutions with two different aggregation levels. 
Consequential cycles performed on each produce a numbers of differently 
purified samples. The final procedure was defined comparing DLS 
measurements of about 8 samples, till the two results from each cycle returned 
similar values. In summary, the samples underwent sonication for 15 min and 
then centrifuged for about 6 minutes at 12,000 rpm (14,000 g
-1
); the 
supernatant is collected, sonicated for 7 more minutes, and centrifuged one 
more time. The resulting supernatant is collected and used during experiments. 
Iron digestion and concentration measurement 
The Fe concentration of every sample used is measured by ICP-OES 
(Inductively Coupled Plasma Optical Emission Spectrometer) analysis. This 
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system requires particles to be totally digested in ions before reading. Efficient 
digestion methods, one for hydrophobic and one for hydrophilic solvent, have 
been identified by comparing a positive control of known particle synthesized 
and provided by our collaborator at RICE University of Houston, Texas. 
Hydrophilic formulations of SPIOs are digested by diluting a known volume 
in 400 µl of HNO3 and heated up to 140 °C on a hot plate till the solution is 
dried; then additional 400 µl of H2O2 is added to the vial and allowed to 
evaporate to dryness. The second cycle was performed by addition of in HNO3 
and lastly followed by addition of freshly prepared aqua regia. Finally, the 
digested sample is diluted in 5 ml of HNO3 at 2% and processed. Hydrophobic 
samples are digested using a similar procedure. To avoid binding of iron oxide 
NPs to silicon oxides of glass vial, a 100 µl of acetonitrile was used to pre-
wash the vial. Digestions and ICP measurements are always performed at least 
in triplicates plus a digestion control. Calibration curve is built with 0, 0.05, 
0.5, 5, and 50 ppm points, by consecutive dilution of commercial available 
metal standards. 
Electron microscopy imaging 
Two magnetization systems are used for imaging at the micro- and 
nano-scale. (i) A scanning electron microscope (SEM) - FEI Nova Nano- SEM 
230 - permits ultra-high resolution imaging (down to tens of nm) at high and 
low vacuum in presence of non-conducting and contaminating materials. 
Samples for SEM are prepared by dropping a small suspension of nanoparticle 
(~2 µl) onto a polished silicon wafer and then dried at room temperature. After 
drying, high temperature sensitive particles, as the polymeric-based 
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nanoparticles, are coated with 5-10 nm of platinum by electro sputtering, 
Cressington 208HR, before imaging. (ii) A transmission electron microscope 
(TEM, JEM-2100F, JEOL Ltd) also provides an insight into the inner 
structural composition where its resolution reach below sub-nanometric 
ranges. In brief, samples were prepared upon deposition onto the surface of a 
TEM grid (Ted Pella, Inc., Form var/Carbon 400 mesh, Copper, approx. grid 
hole size: 42µm) and left to dry for ~1 hr. Physico-chemical characterization 
of SPIOs including TEM micrographs of the three commercial SPIO 
preparations are presented in Figure 3-1A, C, and E. From analyses of these 
images and over 100 nanoparticles, the average size of SPIO cores were 
measured to be 5.13 ± 1.07 nm (nominal size: 5 nm); 7.18 ± 1.08 nm (nominal 
size: 10 nm) and 13.86 ± 1.48 nm (nominal size: 14 nm). The core size 
distribution is shown in the bar chart of Figure 3-1B, D, and F. 
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Figure 3-1. Physico characterization of the SPIO formulations. 
 (A, C, E) TEM images of the three SPIO formulations. Magnetic core size 
distribution as quantified from the TEM images reports sizes of (B) 5.13 ± 
1.07 nm, (D) 7.18 ± 1.08 nm, and (F) 13.86 ± 1.48 nm 
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Laser scattering based characterizations 
A dynamic light scattering (DLS) system - Zetasizer Nano ZS, 
Malvern Instruments Ltd – was used to measure hydrodynamic size of 
different populations in a colloidal suspension, and their polysdispersity index 
(PDI); the same instrument uses electrophoretic light scattering to calculate 
zeta-potential of the particles in solution, their electrophoretic mobility, and 
the electrical susceptibility of the whole. Sample solution, possibly diluted in 
DI water, was poured in disposable capillary cells provided by the same 
manufactures. Triplicate of 16-runs measurements were averaged for each 
characterization. For zeta-potential measurements, 3 minutes of delay were 
observed between repetitions, due to residual excitation effects. 
Magnetization characterization 
The magnetic properties of nanoparticles were investigated thanks to a 
superconducting quantum interference device (SQUID) – MPMS-XL by 
Quantum Design Inc. DC magnetic measurement was performed at 300K in 0 
- 50 Oe field. Magnetization and hysteresis curve were collected in the -5 T to 
5 T range starting at zero field at 300K. The sample was prepared by dropping 
at least 300 µl of nanocrystal suspensions at 3000 ppm Fe in an NMR tube. 
The NMR tube was sealed under vacuum and placed into a plastic straw for 
measurements. Data in Figure 3-2 show no appreciable hysteresis (see insets), 
confirming the superparamagnetic behavior of the nanoparticles. For the 5 and 
14 nm SPIOs, large magnetic saturations were measured with Ms ~65 and 82 
emu g
-1
, respectively; whilst far less performing were the 7 nm particles with 
an Ms ~10 emu g
-1
.  
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Figure 3-2. SQUID measurements of 5, 10, and 14 nm Iron Oxides (IOs). 
SQUID measurements confirm superparamagnetic behavior for the particles 
employed in the study. Reported saturation magnetizations are: (A) 62 emu g
-1
 
for 5 nm particles; (B) 10 emu g
-1
 for 10 nm particles; and (C) 82 emu g
-1
 for 
the 14 nm particles 
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 Apparata for magnetic hyperthermia and 3.2. 
ablation therapy 
A total of three apparata were used during electro heating experiments, 
able to generate alternated magnetic fields (AMFs) at i) high frequency, ii) 
low frequency, and iii) high power. The former was developed in the 
laboratory of Prof. Jarek Wosik, in collaboration with the Texas Center for 
Superconductivity, in Houston. The last two systems were assembled within 
the laboratory of Prof. Audrius Brazdeikis, at the same facility. It follows a 
basic description of these apparata. 
 
3.2.1. High frequency field apparatus (>10 MHz) 
This system was built to generate AMF fields in the MHz range, 
between 10 and 55 MHz, and with field strength up to 4 kA m
-1
. A frequency 
synthesizer along with an amplifier is used to drive input power into a LCR 
resonator. Here, an exciting ring and a resonator coil become critically 
coupled at an impedance matching of 50 Ω. An RF magnetic field is 
established inside the coil at the resonant frequency. The field so generated in 
the solenoid of the resonator is measured using a small loop sensor. The 
resonant circuit shows a Q-factor of ~110, allowing a relatively low input 
power towards a significant amplification of the signal. This particular setup 
considers for temperature stabilization issues, significantly lowering the needs 
for cooling systems since most of the energy is dissipated in the resonator and 
not in the whole system. The resonator solenoid is made of six turns copper 
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tube (3 mm outer diameter) wound into a coil; this possesses a diameter of 15 
mm, a length of 21 mm and a distance per turn of 0.1 mm. Due to the 
importance of a thermally isolated system, a single crystal sapphire (length 22 
mm, width 12 mm, and height 45 mm) water-cooled is housed inside the 
solenoid and works as a heat sink. This design allows for in-vitro tests in a 
cylindrical quartz tube (inner diameter 2.5 mm, outer diameter 3 mm, height 
20 mm) that hosts 180 µl of sample and is mounted in a cylindrical hole 
drilled in a sapphire plate within the solenoid. A fiber optic GaAs temperature 
sensor (T1, Neoptix, Inc.) connected to a multichannel signal conditioner 
(Reflex, Neoptix, Inc.) measures sample temperature every 1 s using. The 
position of the sensor end is controlled by micrometer positioner to be at the 
geometrical center of the fluid. The system is illustrated in Figure 3-3. 
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Figure 3-3. High frequency apparatus. 
(A) Sketch of the high frequency apparatus circuit, consisting in a frequency 
synthesizer and an amplifier which feed a LCR resonator. The sample 
temperature is recorded thanks to an optic probe. (B) The exciting ring is 
critically coupled at with the resonator coil at an impedance matching of 50 Ω; 
the deployed magnetic field has frequency between 10 and 55 MHz, and field 
strength up to 4 kA m
-1
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3.2.2. Low frequency field apparatus (≤ 1 MHz) 
The second apparatus, in Figure 3-4, is able to produce AMFs in a 
discrete range of frequencies between 100 kHz and 1 MHz; the strength of the 
field can be up to 10 kA m
-1
. The field coil is an element in a resonant RLC 
circuit with capacitance varying between 7 and 200 nF, and inductance 
varying in the range 4.5 - 9.1 μH, depending on the frequency. The coil quality 
Q-factor is about 250. High quality RF capacitors and high purity copper coil 
are used in the system to minimize heat dissipation and enhance Q. The 
resonant frequency of the system can be changed by replacing the capacitor 
and/or coil. The field coil temperature is stabilized at 20 ± 0.1 °C by a 
thermoelectric water cooler/heater (ThermoCube 400, Solid State Cooling 
Systems Inc.). This setup is designed to host in-vitro test with cells. In this 
case, temperature is monitored by a nIR thermocamera (A325, FLIR System, 
Inc.) placed above the coil. For heating tests of fluids, it possible to insert a 
cylindrical Plexiglas connected to a separate thermoelectric water 
cooler/heater (T251P-2, ThermoTec, Inc.), which maintains an equilibrium 
temperature of the inner holder at 19.8 ± 0.1 °C. In this case, a glass 
cylindrical tube (inner diameter 5 mm and length 35 mm) holds ~600 µl of 
sample solution and is precisely mounted at the center of the field coil; 
temperature is measured with the same probe described above. 
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Figure 3-4. Low frequency apparatus. 
The field generator receives input from the function generator and the power 
supplier. The temperature of the circuit and the surrounding area of the sample 
are controlled with a thermoelectric water cooler/heater (T = 18 °C). An 
oscilloscope is used to monitor the field generated field. Sample temperature is 
recorded by and optic probe immersed to its center. The field generated is able 
to produce AMFs in a discrete range of frequencies between 100 kHz and 1 
MHz; the strength of the field can be up to 10 kA m
-1
. 
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3.2.3. High power system apparatus (≤ 1 MHz and up to 40 kA m-1) 
The high power system (Figure 3-5) consists in an upgraded low 
frequency apparatus. The magnetic coil can deploy fields up to 50 kA m
-1
 at a 
resonance frequency of ~300 kHz. Briefly, a function generator (33120A, 
Agilent Tech.) is connected to a high power RF generator (800A3A, AR Inc.), 
which feed the RLC circuit; the later consists of a 200 nF condenser couple to 
an inductance of 1.45 µH, which consists of a 7 turns, high grade copper coil, 
3 cm wide and 4 cm tall; quality Q-factor is ~100. The circuit temperature is 
kept in the 19 – 25 °C range by a thermoelectric water cooler/heater (RC7BD, 
Thermotec Inc.). The generated field is constantly monitored by a multimeter 
(DMM2001, Kheytlhey) and an oscilloscope (TDS 3012, Tektronix). The 
system is designed for small animal experiments, and the same nIR camera 
previously described is used to record the temperature. 
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Figure 3-5. High power apparatus. 
The function synthesizer feeds an 800W RF power generator which in turn 
provides the input for the field generator. Two chillers refrigerate the circuit (T 
= 25 °C) and the sample holder (T = 18 °C), separately. The generated field is 
monitored by an oscilloscope and a multimeter; the sample temperature is 
recorded using a nIR camera. This system can generate a field up to 50 kA m
-1
 
and a frequency ~300 kHz 
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3.2.4. Homogeneity of the magnetic field 
In order to assess the homogeneity of the magnetic field, which can 
highly affect heating performance, 5 drops (~6 l) of highly concentrated 
SPIO solution, are deposited in 5 different spots within the magnetic coil. The 
drops were equally spaced and deposited radially on a petri dish, placed within 
the spires of the solenoid. Diameter of the drop is ~3 mm, spaced between 
each other of ~1 mm (Figure 3-6A and B). During the field exposure, 
temperature maps is acquired with the IR camera above reported, and the 5 
different spots temperature T(t) is continuously monitored (Figure 3-6C). 
Testing for statistical significance, it results that there is no statistically 
significant difference (p >> 0.05) between the temperatures of the 3 most inner 
drops, for t  50 s. As described in details in paragraph 2.3 the heating 
property of nanoparticles exposed to excitation is commonly quantified by the 
SAR, which is directly proportional to the temperature evolution first 
derivative in t = 0 (Equation (2-33). Percentage variation within the 6 %, and 
no statistical difference of SAR for these 3 drops (923, 1003 and 1022 W kg
-1
) 
confirms a confident valuation of homogeneous field deployed within ~10 mm 
from the center of the coil (see Table in Figure 3-6). Vial used in fluid 
experiments regularly fall in this range; care is taken during cells and in-vivo 
experiments in order to remain within the confirmed area.  
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Figure 3-6. Homogeneity verification of the deployed field. 
(A) Five drops of nanoparticle fluids are posed radially inside the magnetic 
coil and (B) the temperature recorded using a thermocamera. (C) The 
temperature profiles are plotted versus the time and show a negligible 
variation in temperature (except for the drop next to the coil). The inset show 
detail on the first seconds of heating; the difference between the first 
derivative of the inner 3 spots (within ~10 mm radius) is below the 6 %. 
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 Results 3.3. 
3.3.1. SAR experimental setup 
5, 10, and 14 nm SPIOs commercially available formulations were 
purified as described above. The resulting purified sample (1x) was diluted in 
DI water to obtain 0.1x, 0.3x, 0.5x, and 0.7 x concentrations. Electro-heating 
experiments were then conducted under 4 different field conditions: i) ~30 
MHz and 4 kA m
-1
; ii) ~1 MHz and 5 kA m
-1
; iii) 500 kHz and 10 kA m
-1
; iv) 
~200 kHz and 9 kA m
-1
. Exposure time was 12 min for (i), and 20 min for the 
others setups. Preceding every experiment, samples were sonicated for 2 
minutes to dissolve any possible aggregate and to homogenize the solutions. 
At least six repetitions were performed per group. Before each single 
experiment the probe end was cleaned with isopropanol, and DI water was 
used to re-check calibration of the apparatus at intervals of about six 
experiments. The outcome of each experiment is the temperature - time curve 
T(t) from which the maximum rise in temperature T and the SARf of the 
solution can be readily extracted. The specific SAR of the particles at test was 
extrapolated following the calculations in following paragraph 3.3.2. 
 
3.3.2. Correct computing of the specific absorption rate 
Correct quantification of the SAR from experimental data was 
investigated comparing and averaging results from two procedures. 
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Fitting method 
Temperature variation T(t) with time was fitted over the whole 
duration of the exposure (Figure 3-7A and C) and used to calculate the 
derivative T’(t) at time t = 0 s; then, SARfit is obtained based on Equation 
(2-35). Results from all in-vitro experiments with colloidal fluids were 
processed using Mathematica software to interpolate measured data points 
with Equation (2-31). 
Differential method 
At the same time, for each measurement, few experimental points next 
to the origin (t = 0 s) were considered to estimate the time derivative T’(0), 
exploiting the very mathematical definitions of first order derivative and 
differential quotient:  
t
)t(T)tt(T
lim
dt
)t(dT
)t(T
0t 





 
[K] (3-1) 
Then, initial temperature rate (and related SAR) was estimated as a function of 
the time interval t based on the formula 
NP
p
t
m
c
t
TtT
SAR 




)0()0(
 [W kg
-1
] (3-2) 
The choice of the correct time interval must be based on the linearity of the 
time derivative, as for the considerations in section 2.3.1. It proceeds as 
following. As ∆t reduces from large values, SARt progressively increases till 
it reaches plateau and its dependence from ∆t is negligible. At further smaller 
time intervals, SARt begins changing erratically and tends to rapidly increase 
as ∆t approaches zero. On the other side, for time intervals ∆t increasing 
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beyond the temperature T(0+∆t) is approached with no more significant 
variation in the increment T(0+∆t) – T(0). The proper time interval ∆t over 
which SARt is constant highly depends on the experimental conditions 
(Figure 3-7B and D).  
The percentage difference between SAR values computed via the 
differential and interpolating methods is typically within 5 %, but it can 
reaches ~10 % if the measurement is not accurate. 
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Figure 3-7. Comparisons between computational SAR methods. 
The two modes to calculate particles SAR are compared for 2 IOs 
formulations: (A,B) 7 nm Magnetite in 30 MHz / 4 kA m
-1
 field and 0.23 mg 
ml
-1
 concentration; and (C,D) 5 nm in 0.5 MHz / 10 kA m
-1
 at 3.5 mg ml
-1
. 
SARfit computed by fitting the temperature profile are calculated as (A) 
1608.99 W kg
-1
, and (C) 65.65 W kg
-1
; SARΔt calculated on the Δt increment 
are (B) 1561.34 W kg
-1
 and (D) 57.79 W kg
-1
. The differences between the 2 
calculation approaches are 3 % and 12 % for the 7 nm particles and the 5 nm 
one, respectively. 
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3.3.3. Hyperthermic performance at high frequency field 
Using the high-frequency field apparatus described in section 3.2, the 
hyperthermic properties of the SPIOs were characterized under different 
conditions at 30 MHz (RF regime). Results are presented in Figure 3-8, for 
the 5 and 7 nm SPIOs. The total temperature variation T, fluid SARf and 
nanoparticles SAR for the 5 and 7 nm SPIOs are plotted against the iron 
concentration in Figure 3-8A, B and C, respectively. A temperature increase 
of 15-20 C was observed over a wide range of nanoparticle concentrations, 
namely varying from 0.022 to 0.33 mg ml
-1
. The 7 nm particles heated up the 
solution slightly more than the 5 nm particles, but the difference is not 
statistically significant. Even more intriguing are the values derived for SARf 
and SAR. A biphasic behavior is observed for the SARf with a maximum 
occurring at about 0.1 mg ml
-1
 (Figure 3-8B). On the other hand, the SAR 
decreases continuously as the nanoparticle concentration increases from 0.022 
to 0.33 mg ml
-1
. No statistically significant difference is observed between the 
5 and 7 nm SPIOs, for both measured SAR.  
Based on the definitions of SAR and following the current literature 
[76, 77, 79, 82, 93], these results are intriguing in that it was expected i) a 
fixed SAR independent from the iron concentration; ii) a steady growing T 
and SARf with the iron concentration; iii) statistically significance difference in 
T and SAR between the 5 and 7 nm particles, which have very different 
magnetic properties (see Figure 3-2B and C). 
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Figure 3-8. Hyperthermic performance at high frequency field (30 MHz). 
(A) Absolute temperature increase; (B) ΔT specific absorption rate of the 
solution (SARf); and (C) specific absorption rate of the magnetic nanoparticles 
(SAR) as a function of the iron concentrations in solution, for the 5 and 7 nm 
SPIOs (30 MHz and 4 kA m
-1
). The biphasic behavior can be noted for ΔT and 
SARf. No significant difference can be appreciated for 5 and 7 nm SAR, both 
decreasing with the increase of Fe concentration. 
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3.3.4. Non-specific heating at high frequency field 
Puzzled by the results shown in Figure 3-8, the T and SARf values for 
a pure solution of NaCl are measured and compared to those registered for the 
SPIOs. Results are presented in Figure 3-9. Different concentrations of NaCl 
were considered, namely ranging from 0 (pure, DI water) to 300 mM (supra-
physiological salt concentrations). The electrical conductivity of the solutions 
was also measured by electrophoretic light scattering. As expected, Figure 
3-9A shows a linear increase in the electrical conductivity of the NaCl solution 
with the salt concentration.  
The T and SARf for the NaCl solutions at different salinities were 
measured using the same approach described above for the SPIOs. This is 
shown in Figure 3-9B and Figure 3-9C (dot-dashed line with cross) as a 
function of the electrical conductivity of the solution, rather than the salt 
concentration. Knowing that non-specific heating in the RF regime can be 
associated with ions dispersed in solutions [79], the electrical conductivity was 
also measured for the 5 and 7 nm SPIO solutions. Then, the data from Figure 
3-8A and B were rephrased in terms of the electrical conductivity of the 
solution rather than its iron concentration. Thus, Figure 3-9B and 3C show the 
T and SARf variation over the electrical conductivity of the solutions with 
NaCl (dot-dashed line with cross), 5 nm SPIOs (solid line with diamond) and 
7 nm SPIOs (dashed line with square).  
The trends and absolute values for the three sets of data are very 
similar with almost no statistically significant difference within the range 0.05 
to 1.89 S m
-1
. The intriguing biphasic behavior noted above for the SPIOs 
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(Figure 3-8B, C) is here observed also for the free NaCl solution, implying 
that it might be related to non-specific rather than IOs specific heating. NaCl 
SAR profile is in agreement with the behavior reported by Beković and 
Hamler in [79]; in their study they infused solution enriched in NaCl within 
the malignant tissue prior exposure to RF fields. Also, a statistically 
significant difference between the SPIOs and the NaCl solutions is only 
observed for larger electrical conductivities, namely > 1.5 S m
-1
. Note that a 
physiological solution (150 mM of NaCl) exhibits an electrical conductivity of 
1.8 S m
-1
. For ~300 mM of NaCl, the electrical conductivity is 3.6 S m
-1
. 
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Figure 3-9. Non-specific heating at high frequency field (30 MHz). 
(A) Linear relationship between NaCl concentration of water solution and its 
electrical conductivity. (B) Absolute temperature increase ΔT and (C) fluid 
specific absorption rate SARf as a function of the electrical conductivity for 5, 
7 nm SPIOs and saline solutions (30 MHz and 4 kA m
-1
). 
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These differences are analyzed in more details in the bar charts of 
Figure 3-10 and Figure 3-11. The first shows the non-specific nature of the 
heating by presenting the T and SARf for diluted and centrifuged colloidal 
solutions. Here the behavior of two particle formulations (5 and 7 nm SPIOs) 
is considered and compared with NaCl solutions. In particular, the original 
samples, provided by the vendor in a concentration of about 1.0 mg ml
-1
 and 
with an electrical conductivity of 1 S m
-1
, were centrifuged. The collected 
supernatant was then exposed to AMF (centrifuged samples). 
Although, the concentration of iron in the centrifuged solution is lower 
than in the original sample (see table in Figure 3-10), no statistically 
significant difference is observed for T and SARf. Indeed, centrifugation 
process does not alter the ionic concentration and the electrical conductivities 
remain the same. Then, original samples were diluted about five times in DI 
water, thus reducing both the iron and ionic concentration; consequently, the 
electrical conductivity is decreased to about 0.2 S m
-1
 (diluted sample), closer 
to the SARf peak for salt solution (Figure 3-9B, C). In this case, a slight 
variation (increasing) in T and SARf is observed as compared to the original 
sample. 
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Figure 3-10. Comparison of non-specific heating at high frequency field. 
Total temperature variation ΔT (A) and SARf (B) of 5 and 7 nm SPIO 
formulation with NaCl solutions. For each sample the comparison is between: 
i) the original sample; ii) the supernatant obtained after centrifugation; and iii) 
a further re-dilution in DI water. The table lists all Fe concentrations and 
electrical conductivities. 
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The bar chart of Figure 3-11 shows the variation of T and SARf for 
three different salt concentrations, namely 135 (physiological), 210 and 300 
mM (supra-physiological), and the considered three SPIO preparations. A 
minimal difference between the 5 and 7 nm SPIOs and the NaCl solution is 
observed under these conditions, with a SARf for the formers being 2-fold than 
the latter (~900 and 450 W kg
-1
). No significant difference was observed even 
for the 14 nm SPIOs. These results confirms that in the physiological and 
supra-physiological regime, the 5 and 7 nm SPIOs heat up the solution with 
SARf that are larger than the NaCl solution alone, but the contribution of non-
specific heating is comparable with the heat generated by the magnetic 
nanoparticles. 
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Figure 3-11. Mild heating of SPIOs at high frequency field (30 MHz). 
 (A) The absolute temperature increase ΔT and (B) SARf of 5, 7, 14 nm SPIO 
and NaCl solutions. The comparison is between the same samples at1.7, 2.6, 
and 3.5 S m
-1
. The table lists the exact values of electrical conductivity and Fe 
concentrations for the tested sample solutions (30 MHz and 4 kA m
-1
). 
 
  
73 
 
 Design maps for local hyperthermia and ablation therapy 
3.3.5. Hyperthermic performance at low frequency field 
The hyperthermic properties of the SPIOs were also characterized at 
200, 500 and 1,000 kHz using the second apparatus described section 3.2.2. 
The data are plotted in Figure 3-12. No appreciable heat is generated by NaCl 
solutions, even at physiologically relevant salt concentrations, for all 
frequencies tested. This confirms that for sufficiently low frequencies, non-
specific heating is negligible. Next, the 5, 7, and 14 nm SPIOs were 
investigated under different conditions with a concentration of 0.4 mg ml
-1
. 
However, both the 7 and 14 nm SPIOs did not exhibit any significant heating 
at these lower frequencies, possibly due to the insufficient magnetization of 
the first particle and large size of the second. The inferior performances of 14 
nm particles can be attributed to their size and also to the surface coating of 
the particles [83].  
The T and SARf of the 5 nm SPIOs show a concentration and 
frequency dependent behavior, in agreement with the linear response theory 
[54]. Figure 3-12 shows a linear behavior of T and SARf with the Fe 
concentration, whereas the particle SAR is almost constant over the considered 
range of concentrations. Also in Figure 3-12F, comparing the cases of f = 200 
and 500 kHz, it can be readily appreciated a SAR increase of 2.5 times (from 
6,400 to 16,800 W kg
-1
) consistent with the corresponding variation in f (H 
~10 kA m
-1
). Similar observations can be drawn for the other combinations of 
f and H. 
In Figure 3-12, the results show that 5 nm SPIOs at a concentration of 
5 mg ml
-1
 would generate a temperature increase T of about 10 C after 
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exposure to a 500 kHz field with a strength of just 10 kA m
-1
. These data 
demonstrate that at low frequencies (< 1 MHz) non-specific heating is 
virtually absent and significant increments in temperature can be generated 
and sustained for long periods of times. Note however that the maximum 
temperature increase depends on the volume of solution and the environmental 
conditions (see section 2.2). Therefore, a feasibility analysis must also include 
the modeling of the heat generated from the metal nanoparticles, its transfer to 
the surrounding tissue, and corresponding temperature increase over time. The 
following paragraphs deal with these considerations, reporting the results 
obtained from finite elements simulations. 
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Figure 3-12. Hyperthermic performance at low frequency fields (0.2; 0.5; 
and 1 MHz). 
(A, C, E) ΔT, SARf, and SAR as a function of the iron concentration under 
different AMF operating conditions (200 kHz and 9 kA m
-1
; 500 kHz and 10 
kA m
-1
; and 1 MHz and 5 kA m
-1
). (B, D, F) Same ΔT, SARf, and SAR for 
three different AMF operating conditions grouped by iron concentration. (0.5, 
1.5, 2, and 3 mg ml
-1
). 
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3.3.6. Computational modeling of the temperature field within the 
tissue 
The temperature field is quantified using a finite element method, as 
described in the paragraph 2.4. A schematic representation of the 
computational domain is previously shown in Figure 2-4. Here 1 is the 
healthy tissue surrounding the tumor located in 2, where the SPIOs are 
uniformly distributed. Per the performed experimental work, two conditions 
were modeled: high frequency with f = 30 MHz and low frequency with f = 
500 KHz. In the first case, a nanoparticle concentration of 0.22 mg ml
-1
 was 
considered. Heating capacity are as for Figure 3-11B, assuming for the tissue 
SARt the same as found for physiological concentrations of salt solution (SARt 
= 450 W kg
-1
 for simple tissue in Ω1 and SARf = 900 W kg
-1
 for tissue and IOs 
in Ω2). The corresponding volumetric fraction   was about 4.310
-6
, thus it 
was reasonably assumed that the presence of the nanoparticles did not affect 
the physical properties of the tissue. The value for the heat exchange 
parameter
v
h was derived by referring to the heating of a pure NaCl solution 
(Figure 3-11A). Considering a single domain with 1
1,
0

 sw
bl
 a heat 
exchange coefficient hv = 1.6510
-3
 W mm
-2
 K
-1
 reproduces the observed 8 °C 
increase in temperature for a NaCl solution with SARNaCl = 450 W kg
-1
. Note 
that this value of 
v
h  is in agreement with data presented in literature [74]. All 
the parameters used in the simulations are listed in Table 2-1. 
The temperature field was derived by solving Equations (2-36) and 
(2-37) for T(  , t), considering different values of 10
2,bl
0
1,bl
s0w,w

 , with 
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boundary conditions (2-38), (2-39), (2-40) and initial condition (2-41). Figure 
3-13A shows the temperature distribution within the computational domain at 
time t = 600 s, for 10
1,
018.0

 sw
bl
. The upper portion of the panel gives the 
temperature field resulting from the heat generated by the SPIOs deposited in 
2 in addition to the non-specific heating; whereas the bottom portion of the 
panel shows the results corresponding to the sole non-specific heating. There 
is clearly an increase in temperature within the tumor domain (2) due to the 
presence of the SPIOs, however the temperature difference between the two 
conditions is only of about 3 C, being the max temperatures equal to  44 and 
 41 C, respectively (see Figure 3-14A, red lines). Also, the healthy tissue 
surrounding the tumor is exposed to significantly high heat doses with a 
minimum temperature of  42 C, deriving from the non-specific heating of 
the tissue as well as from the diffusion of heat from the tumor. Figure 3-14A 
shows the increase with time of the temperature in the center of the domain 
where the absolute maximum temperature was registered within the whole 
domain, for different perfusion levels of the healthy tissue. Note that within 
200 s (3 min), the system reached almost the steady state. In Figure 3-13A, 
the relevance of non-specific heating can be immediately deduced by 
comparing the data for the solid (specific heating) and dashed (non-specific 
heating) lines.  
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Figure 3-13. Computational modeling of the temperature field within a 
biological tissue. 
Temperature field at equilibrium for a uniform distribution of SPIOs. (A) 
Simulation of high frequency (30 MHz) heating inside the tumor (SARf = 900 
W g
-1
), and non-specific tissue heating in the outer region (SARf = 450 W g
-1
) 
(blood perfusion wbl,1
0  = 0.018 s
-1
). (B, C) Low frequency (500 kHz) 
simulations of temperature field at equilibrium for a uniform distribution of 
SPIOs at two different concentrations (50 and 200 mg ml
-1
). All the bottom 
half-panels refer to non-specific heating alone (cNP = 0). 
 
Figure 3-14. Temperature increase in the modelled areas. 
Temperature increase with time in the tumor region for different blood 
perfusion levels of the surrounding, healthy tissue. (A) Solid lines refers to 
specific heating inside the tumor (f = 30 MHz), and dashed lines refers to non-
specific heating alone.(B) Solid lines and dashed lines refer to 50 and 200 mg 
ml
-1
 of SPIOs, respectively (f = 500 kHz). 
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In the case of low frequency fields, the non-specific heating is 
negligible and heat is solely generated within the tumor domain 2 where the 
SPIOs are deposited. Therefore, SARt = 0 W kg
-1
 everywhere within the 
computational domain. Considering the same geometry and parameters as for 
the high frequency case, the temperature field is provided in Figure 3-13B and 
C for two different SPIO concentrations, namely 50 and 200 mg ml
-1
. The 
SAR used was extrapolated from experimental results presented in Figure 
3-12E, F for the 5 nm SPIOs, assuming a linear increase of the specific 
absorption rate with the particle concentration. In the both bottom panels of 
Figure 3-13B and C no increase in temperature is observed (lack of non-
specific heating); whereas, as expected, in the upper panels the temperature 
increases with the concentration of the SPIOs. At the highest concentration of 
200 mg ml
-1
, the maximum temperature of ~47 C is reached uniformly within 
the tumor domain 2. In this case, the temperature increase within the healthy 
tissue has to be ascribed solely to heat transport from the central tumor domain 
2. Figure 3-14B shows the increase with time of the temperature in the 
center of the domain for different perfusion levels. Even in this case, steady 
state conditions were reached within almost 200 s (3 min). Note that all these 
data correspond to the case in which no perfusion occurs within the tumor 
tissue, which indeed leads to slightly higher temperatures within the 2 
domain. 
Using the same computational framework, a systematic analysis can be 
performed to quantify the equilibrium temperature under different conditions, 
and in particular for different values of the SPIO concentration cNP and SAR. 
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This is shown in the bar chart of Figure 3-15A, which confirms a steady, 
linear increase in the maximum temperature achieved in the tumor tissue with 
cNP and SAR. It is well accepted that tissue thermal ablation can be efficacious 
only by achieving temperatures equal or larger than 50 C for sufficiently long 
periods of time. Mild ablation or hyperthermia can be achieved at 
temperatures equal or larger than 42 C. Therefore, choosing these as target 
temperatures, two lines can be drawn in the cNP - SAR plane as shown in 
Figure 3-15B.  
These are quasi-linear lines in a double logarithmic plot for the range 
of concentrations and specific absorption rates considered, and are described 
by the equation 
bSARc
a
NP
  [W m
-3
] (3-3) 
where a = 1.0616 and b = 2.2714106 W m-3 for T = 42 C; a = 1.0737 and b = 
7.1565106 W m-3 for T = 50 C. Three characteristic operating regimes can 
be identified in Figure 3-15B: i) insufficient heating for cNP - SAR values 
falling below the hyperthermia curve (Teq< 42 C, green area); ii) 
hyperthermia for cNP - SAR values falling between the hyperthermia and 
ablation curves (42 CTeq<50 C, white area); and iii) ablation for cNP - SAR 
values falling above the ablation curve (Teq 50 C, red area). Figure 3-15B 
provides a design map for rationally selecting the hyperthermic treatments and 
identifying the proper route of administration – systemic versus intratumor 
injection – depending on the magnetic and biodistribution properties of the 
nanoparticles. Note that this result is general in that it can be applied for any 
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nanoparticle, including ferromagnetic particles, for which the SAR and local 
tissue concentration are known.  
It should here be emphasized that nanoparticles, especially if 
systemically injected, would not distribute uniformly within the target tissue. 
Their concentration is expected to be larger at sites with higher vascular 
permeability and blood perfusion; and this will vary within the tumor mass as 
well as with the type and stage of the disease. Nonetheless, the assumption of 
a uniform distribution of nanoparticles within the target tissue provides a 
conservative estimation on the maximum temperature that can be reached 
within the region of interest, for a given total number of particles.  
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Figure 3-15. Design map for local hyperthermia and ablation therapy. 
(A) Maximum absolute temperature reached in the tumor center for different 
nanoparticle concentrations, cNP and specific absorption rates, SAR. (B) 
Isotemperature lines for tissue hyperthermia (Ttissue = 42C) and thermal 
ablation (Ttissue = 50C) drawn as a function of the nanoparticle concentration 
cNP and specific absorption rate SAR. 
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 Discussion on the clinical feasibility of 3.4. 
thermal therapies 
The data presented in Figure 3-15B demonstrates that in order to achieve 
tissue hyperthermia and thermal ablation, sufficiently large values of SAR and 
SPIO concentrations are required. Therefore, it is here important to discuss 
strategies to improve the hyperthermic properties and tumor accumulation of 
magnetic nanoparticles. 
Section 2.5 describes the dependence of the particle intrinsic loss power 
(ILP) from features such as the size, shape and surface properties of the 
SPIOs. Once the optimal nanoparticle properties are established, the SAR can 
be still tuned by controlling the operating conditions of the AMF apparatus 
(meaning frequency f and strength H0) following the linear response theory. 
Theoretical and experimental works have confirmed that, within the AMF 
regime here of interest, the specific absorption rates would grow linearly with 
the frequency (f) and with the second power of the AMF strength (H2). 
This is also confirmed here by the data presented in Figure 3-12. The 5 nm 
SPIOs used in the present work provides an ILP value of 382·10-12 (m2 s-1 A-
1
)
2
. By increasing the field strength up to 50 kA m
-1
, their SAR would grow up 
to  5·105 W kg-1, and the corresponding concentrations needed for 
hyperthermia and ablation therapy would be  2 and 5.5 mg ml-1, respectively, 
as from Equation (3-3).  
It is here important to recall the seminal work done by Atkinson and 
Brezovich on magnetic hyperthermia treatments and patient discomfort. In 
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particular, Atkinson and colleagues [94] proposed a maximum limit for the 
product f·H = 4.85x108 A turns m s-1. This number was based on discomfort 
during measurements performed on patients over 20 years ago. In the same 
work, the authors have clearly reported that the maximum tolerable dose 
depends also on the equipment, duration, location and extension of the region 
of treatment; and on the specific patient. Therefore, the value 4.85·108 A turns 
m s
-1
 should be considered as an indication rather than an absolute strict limit. 
The majority of the in-vivo experiments available in the literature have 
dealt with locally, intratumorally injected nanoparticles with concentrations 
ranging from a few mg ml
-1
 to a few hundreds of mg ml
-1
. Therefore, the 
questions should be posed on whether sufficient concentrations of SPIOs for 
hyperthermia and thermal ablation could be achieved within a tumor mass via 
systemic injection. A very elegant study on the biodistribution of radio-labeled 
SPIOs have been published demonstrating tumor accumulation on the average 
of 1.0% ID g-1 for up to 70 nm in size nanoparticles [95]. This level of tumor 
accumulation for systemically injected nanoparticles could be enhanced by 
following two strategies: i) encapsulating SPIOs into larger carriers that are 
rationally designed to lodge within the diseased vasculature of tumors [96, 97] 
and ii) magnetically dragging the SPIOs within the tumor mass using external 
forces, generated by static magnetic fields [98, 99]. In order to complete the 
investigation on the rational design of IOs-based nanodevices for 
hyperthermic treatments, both these approaches was also explored. Results are 
presented in the next Chapter 4. 
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An issue that can arise when performing experiments on mice is non-
specific major uptake of SPIOs in other organs, such as the liver or spleen. 
Accumulation here can highly exceed the level of 1% ID g
-1
 found in the 
tumor, causing unwanted damage if the whole mouse body is exposed to 
AMFs. Nevertheless, in human application it is possible to localize the area of 
exposure with highly focused field, reducing the risk of unwanted damages. 
Cytotoxicity analysis conducted on SPIOs in mice, rats and humans had 
shown from mild to tolerable side effects up to concentrations of 4’000 mg Fe 
kg
-1 
[100, 101]. This would imply an injected dose of ~100 mg Fe for a 20 g 
mouse. Thus, considering of 1% ID g
-1
 tissue accumulation data given above, 
a total SPIO concentration within the tumor mass of ~1.0 mg Fe ml
-1
 would be 
expected (1 g ≈ 1 ml of tissue). For these levels of tumor accumulation, 
hyperthermia and thermal ablation could solely be achieved via the systemic 
injection of SPIOs with a SAR106- 107 W kg-1. This would be only one order 
of magnitude larger than the values obtained here with commercially available 
5 nm SPIOs stimulated at 500 kHz and 50 kA m
-1
. Referring to the Table 2-2, 
the nanoparticles presented in [62] with a SAR 4106 W kg-1 at 500 kHz and 
37.3 kA m
-1
 could reach such high values by increasing the field strength to 50 
kA m
-1
 (7.2106 W kg-1) and the minimum concentrations required for 
hyperthermia and ablation would be of 0.1 and 0.3 mg ml
-1
, respectively.  
Based on the above reasoning, one would conclude that hyperthermia 
and thermal ablation of cancerous tissues are feasible with the systemic 
injection of magnetic nanoparticles for sufficiently high SAR values, as given 
by Equation (3-3). 
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  A novel class of magnetic 4.
nanoconstructs 
Chapter. 4 expounds on the optimal design of a superparamagnetic iron 
oxides particles (SPIOs) based system, merging heating proprieties with other 
typical features of SPIOs.  
The magnetic properties of SPIOs have been exploited for both imaging, 
diagnosis, and therapy in diverse biomedical applications [86, 102-104]. 
Indeed, SPIOs offer a significant shortening of the transverse relaxation time 
of water and can be efficiently used as T2-MRI contrast agents [105-107]; they 
are generally made of biodegradable iron that, upon dissolution, can enter the 
physiological metabolism of cells limiting possible concerns on toxicity [108-
110]. Moreover, their surface can be chemically modified using a variety of 
well-established protocols to confer specific molecular and electrostatic 
properties [111, 112]. Finally, the intrinsic magnetic character allows for 
improved target accumulation through the use of directed magnetic gradient 
field [113, 114]. 
A plethora of work have been dedicated to develop SPIOs and SPIO-based 
systems, with enhanced MRI or thermal ablation performance. Nevertheless, it 
seems that no publications yet investigate the possibility to exploit more of 
these capacities at the same time. The potential of SPIOs to perform 
simultaneously much different functionalities strongly appeals to the idea of a 
more complete nanodevice for cancer treatments. 
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In order to modulate the magnetic properties of iron oxide NPs, several 
strategies were proposed in recent literature, as that of forming clusters of 
SPIOs [115, 116]. The mobility of the water molecules within and around the 
cluster is thereof altered and, depending on the SPIO spatial organization, the 
cluster can present higher transversal relaxivities r2 as compared to the 
individual SPIO [117, 118]. Other investigator systematically had analyzed the 
effect of the size and surface properties of SPIOs in numerous manuscripts 
showing that transversal relaxivity can be boosted by increasing the metal core 
size up to  30 nm [119, 120]; whereas the type and thickness of polymer 
coatings can be detrimental to r2 in that it could negatively affect the diffusion 
of the water molecules and their interaction with the metal core [121]. 
Recently, the shape of the SPIOs has been also explored as a parameter for 
optimizing magnetic response. Needles, star-shaped and cubical particles have 
been reported by several groups. Among the different iron oxide particles 
(IOs) shapes, iron oxide nanocubes (NCs) demonstrated remarkable MRI and 
thermal ablation properties [63, 108, 122-126]. 
Following these leads, three different formulations of magnetic 
nanoconstructs were here generated by confining multiple, individual SPIOs 
into a polymeric matrix. The nanoconstructs were named: i) Hybrids 
NanoParticles (HNPs); ii) Discoidal Polymeric Nanoconstructs (DPNs); and 
iii) Magnetic NanoFlakes (MNFs). These were characterized for their physico-
chemical properties, stability in solution over time, relaxometric and 
hyperthermic properties, cytotoxicity, and in flow magnetic targeting. The 
third formulation was especially defined as a multi-functional device able to 
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perform at the same time in all the above mentioned SPIOs features. 
Additionally, a preliminary in-vivo study confirms the hyperthermic 
potentiality of this last nanoconstruct. 
 
 Synthesis, physico-chemical characterization, 4.1. 
and cell viability assessment of polymeric 
nanoconstructs 
4.1.1. Particles synthesis 
Synthesis for several particles formulation were approached with the 
assistance of different collaborators, starting with the basic SPIO nano-
particles, which are the focus of this Ph.D. work, and moving to more complex 
polymer-based structures.  
Spherical and cubical IOs 
With the help of Dr. Minjung Cho, spherical (several sizes from 5 up 
to 20 nm) and cubical (22 nm) IO nanoparticles were synthesized following 
the protocol in [127, 128].  
The procedure for spherical IOs was the following: 0.178 g of 
FeO(OH), 2.26 g oleic acid (OA) and 5 g 1-ODE were mixed in a 100 ml three 
neck flask and heated to 120 °C for 2 hours to remove residual water and 
further heated to 240 °C for 30 minutes to synthesize iron carboxylate, iron-
oleate; then, the reaction mixture was heated to 320 °C for 2 hours under N2 
condition; to purify the resulting black colloidal nanocrystals, 20 ml of 
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methanol and 20 ml acetone were added to 5 ml resulting colloidal solution 
and centrifuged at 4150 rpm for 30 minutes; the precipitates at the bottom 
were re-dispersed using hexanes and this process was repeated six times. 
Finally, 10 nm iron oxide nanocrystals were purified and dispersed in hexanes. 
For 16 nm Fe3O4 nanocrystals, the molar ratio between FeO(OH) and 
oleic acid was changed from 1:3 to 1:5 with all other conditions remaining the 
same. To produce smaller IO nanocrystals (< 5 nm), iron oleate was used as 
the iron precursor. 4 nm IO nanocrystals were prepared using iron oleate 
(0.015 mM, 0.009 g) and oleic acid (0.3 mM, 0.08 g) in 5 g ODE at 320 °C for 
3 hours under the N2 flow. The largest iron oxide nanocrystals (33 nm), 
required a higher molar concentration of FeO(OH), oleic acid, and ODE. 
FeOOH (50 mM, 4.5 g), oleic acid (200 mM, 56 g), and 1-ODE (40 mM, 10 g) 
were first heated to 240 °C for 2 hours and further heated to 320 °C for 12 
hours.  
Synthesis of NC consisted in: 0.71g of iron (III) acetylacetonate, 1.27 g 
of oleic acid, 10.40g of benzyl ether, and 0.41g of 4-biphenylcarbocylic were 
mixed in a three neck flask, then degassed by nitrogen gas (1 hour) before 
reaction. The mixture was heated up to 290 
o
C and left to react for 30 minutes 
and then cooled down and the produced nanocubes could be precipitated by 
ethanol; a magnetic separator of Dexter Magnetic Technologies Inc. (Elk 
Grove Village, IL) is employed to remove supernatant; the purified nanocubes 
were resuspended in chloroform. Iron (III) acetylacetonate, 4-
biphenylcarboxylic acid, and benzyl ether were purchased from Thermo Fisher 
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Scientific Inc. (Waltham, MA). Oleic acid is obtained from Sigma-Aldrich 
Corp (St. Louis, MO). 
Both spherical and cubic IOs were finalized with a thin coating of oleic 
acid, performed as follows [129]: oleic acid (0.95 µM to 9.5 µM) was 
introduced to 1 ml of nanocrystals solution dispersed in ethyl ether (1,500 - 
4,000 mg/l of iron concentration); after stirring the mixture for 24 hours, ultra-
pure water (MILLIPORE, 18.2 MΩ) or 0.1 M sodium bicarbonate (pH 9) 
solution was introduced and stirred for an additional 2 hours; then the sample 
was probe sonicated (UP 50H, Dr. Hielscher) at 60 % amplitude for 10 
minutes to help disperse the material in water. The nanocrystal solution was 
stirred, uncovered for 1 day to completely evaporate the residual organic 
solvents; the purification of water-soluble nanocrystals was carried out using 
ultracentrifugation (optima L-90K ultracentrifuge, Beckman coulter) at 40’000 
rpm for 3 hours twice followed by syringe filtration (pore size of 0.45 µM, 
Whatman NYL); the resulting aqueous solutions were acquired after these 
ultracentrifugation and syringe filtration steps.  
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Figure 4-1. TEM Iron Oxides nanoparticles. 
Transmission electron imaging of (A) freshly synthesized 11 nm spherical and 
(B) 22 nm cubical IOs. The insets show high resolution details. (From Dr. 
Minjung Cho.) 
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Polymeric hybrid particles 
Assisted by Dr. Santosh Aryal, hybrid nanoparticles with a polymeric 
core of PLGA (poly(lactic acid-co-glycolic acid), Lactate Absorbable 
Polymers - DURECT Corporation) mixed with 17 nm sized spherical 
hydrophobic SPIOs and PEG-lipid shell were developed. Synthesis followed a 
single step nano-precipitation method: 200 µg of Egg PC (L-a-
phosphatidylcholine, egg, chicken, Avanti Polar Lipid Inc.) and 260 µg DSPE-
PEG-COOH (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-carboxy-
(polyethyleneglycol)-2000, Avanti Polar Lipid Inc.) were dissolved in 4% 
ethanol at 68 °C; to this solution, PLGA (1 mg, Mn ~50 kDa) and 0.1 mg of 
SPIOs dissolved in acetonitrile (Fisher Sci.) were added drop wise while 
heating and stirring. Then the vial was vortexes for 3 min followed by the 
addition of room temperature DI water (1 ml). The solution mixture was 
stirred at room temperature for 2 h, washed using an Amicon Ultra centrifugal 
filter (Millipore, Billerica, MA) with a molecular-weight cutoff of 100 kDa. 
Finally, the purified HNPs were collected in 1 ml water or phosphate buffer 
saline and stored at 4 °C. The procedure is reported in Figure 4-2. 
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Figure 4-2. Synthesis steps in Hybrid NanoParticles (HNPs). 
The hydrophobic mixture of IOs, Rh B, and PLGA was left dry and then re-
suspended in Acitonitrile. In the meantime lipids were stirred at 60 °C in water 
and then added with the first component when still on the stirring. The 
obtained solution is purified several times by centrifugal filtering and 
resuspended in DI water 
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DPNs 
In collaboration with Dr. Jaehong Key, DPNs were synthesized 
following the procedure detailed in [130]. Briefly: a silicon master template 
provided by the Dept. of Bio/Nanotechnology and /Engineering, University of 
Magna Graecia, Italy, was used in the fabrication of hydrogel templates. 5 ml 
of PDMS:elastometer (10:1) was transferred onto the silicon master template. 
To completely polymerized PDMS solution, it was placed at 60 °C in oven. 
For preparation of PLGA, 30 mg of powder were dissolved in 
dichloromethane (DCM). 100 µl of the diluted solution were mixed with 0.5 
mg of 5 nm SPIOs (in toluene) and dried overnight in oven (60 °C). The 
mixture was resuspended 1:1 in 200 µl of DCM; aftermath PEG 
dimethacrylate (10 µl), RhB (0.5 mg), and Photo-initiator (10 µl) was also 
included. This polymeric mixture was loaded on the PVA templates and 
exposed to UV-light further polymerization. After drying, PVA templates 
were dissolved in deionized water at 60 °C and then the DPNs harvested from 
the dissolved PVA templates. Commercially available reagents were utilized 
for the synthesis: Poly(vinyl alcohol) (PVA, Mw 31,000-50,000), Poly(DL-
lactide-co-glycolide) acid terminated (PLGA, lactide: glycolide 50:50, Mw 
38,000-54,000), Poly(ethylene glycol) dimethacrylate (Mn 750) (PEG 
dimethacrylate), 2-Hydroxy-4’-(2-hydroxyethoxy)-2-methylpropiophenone 
(Photo-initiator), and ultras-small SPIO (II,III) (5 nm) were purchased (Sigma, 
St. Louis, MO, USA). Sylgard 184 kit as polydimethylsiloxane (PDMS) and 
elastomer was purchased from Dow Coming Corp (Midland, MI). 
Methacryloxyethyl thiocarbamoyl rhodamine B (RhB) was purchased from 
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Polysciences, Inc. (Warrington, PA). 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) was ordered from 
Avanti Polar Lipids Inc. (Alabaster, AL).  
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Figure 4-3. Discoidal Polymeric Nanoconstructs (DPNs) synthesis.  
A first complementary template in PDMS is obtained from the original Si 
template. From that, a perfect copy of the original template is obtained in 
PVA. A mixture of Rh B, 5 nm iron oxides nanoparticles and PEGylated PLG 
is coated on this last template. The particles are collected upon degradation of 
the PVA and purification. 
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Magnetic NanoFlakes (MNFs) 
Prior to nanoconstruct synthesis, deoxycholic acid-modified chitosan 
conjugate (deoxy-chitosan) was synthesized following the published protocol 
in [131]. Briefly, chitosan (80 mg) was dissolved in a 9/1 (v/v) solution of 
DMSO/water, and then deoxycholic acid (200 mg) activated by EDC/NHS in 
presence of catalytic amount TEA was added, as demonstrated in Figure 
4-4A. The products were then purified by extensive dialysis and lyophilized to 
obtain dry powder. The synthesized deoxy-chitosan was characterized using 
FT-IR spectroscopy (Figure 4-4B). 
Then, the synthesis of the MNFs followed an emulsion procedure, in 
which 10 ml of 1% acetic acid in water containing 750 µg of 1,2-distearoyl- 
sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] (1 
mg ml
-1
 of DI water, Carboxalate-DSPE-PEG - Avanti Polar Lipids, Inc.), 500 
µg of L-α-phosphatidylglycerol (1mg ml-1 of DI water, Egg PG - Avanti Polar 
Lipids, Inc.), and 1 mg of deoxy-chitosan dispersed in 1% acetic acid in water 
(1 mg ml
-1
) were mixed together. 
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Figure 4-4. Deoxy-chitosan conjugation. 
(A) Schematic of Deoxy-Chitosan reaction. (B) FT-IR spectra of chitosan, 
deoxycholic acid, and chitosan-deoxycholic acid conjugate. The characteristic 
bands, amide I (1656 cm
-1
), amide II (1593 cm
-1
), and amide III (1373 cm
-1
) of 
chitosan are intact in both chitosan and chitosan-deoxycholic acid conjugate. 
However, the H-bonded, N–H Stretching, and O–H stretching centered at 
3500 cm
-1
 to 3100 cm
-1
 was slightly modified to small intense band at 
3446 cm
-1
 along with the broad band, which reduces the extent of the H-
bonding due to the conjugation with deoxycholic acid, confirms the formation 
of the conjugates. Likewise, the absorption of alkyl C-H stretching band of 
conjugate decreases as compare to that of chitosan at 2950-2850 cm
-1
 is 
possibly due to the incorporation of alicyclic rings. 
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Finally, for the synthesis of the nanoconstruct 1.1 mg of magnetite 
(Fe3O4) cubes coated with a thin layer of oleic acid dispersed in chloroform, 
was emulsified in the lipid, PEG, the deoxy-chitosan mixture. Following 
overnight evaporation of chloroform, the particles were filtrated 4 times using 
Millipore centrifugal filters to clean any residual of acetic acid and unformed 
particles, and then re-diluted in Milli-Q water or PBS as needed. 
 
 
 
Figure 4-5. Emulsion procedure for Magnetic NanoFlakes (MNFs). 
Lipids and deoxy-chitosan were earlier mixed in a 1 % acetic acid solution at 
room temperature. Hydrophobic solution of nanocubes is then placed at the 
bottom of the tube without further mixing. Emulsion is executed by pro-
sonication of the whozle solution for 1 min. The result was let under hood for 
few hours to let the organic solvent completely evaporate. Finally the solution 
was purified by centrifuge filtering. 
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4.1.2. Chemico-physical characterization 
Physical, chemical, and magnetic characterizations followed the same 
instruments and procedure previously described in Chapter. 3 for SPIOs, 
where possible. Direct light size measurements are not adequate for discoidal 
particles, which not present an aspect ratio close to 1; DPNs measurements 
were therefore performed using an atomic force microscope (AFM). 
Atomic Force Microscope (AFM) 
AFM from Bruker (high-speed Bruker MultiMode AFM – Billerica, 
MA, USA) was employed for a correct analysis of DPNs width and height. A 
silicon tip on nitride lever (spring constant = 0.4 N m
-1
) of 500 nm was 
utilized with in-air scan modality SCANASYST tapping mode, 4 Hz scanning 
rate. DPNs in aqueous solution were prepared by dropped few µl on a cleaned 
silicon wafer and completely dried at room temperature. Last, the silicon 
wafer was directly attached to the magnetic stainless steel disc on the AFM. 
 
4.1.3. Cell Culture 
Cell lines 
Cell experiments in-vitro were performed on the following cell lines: i) 
J-774 macrophages – this macrophage cell line is provided by ACTT and 
cultivated using medium DMEM, 10% FBS, 1% Pen/strep in standard 
conditions of 37 °C and humidified 5 % CO2 atmosphere; ii) HUVECs – 
Human umbilical vein endothelial cells from PromoCell were originally 
cultured in 10 cm petri-dish, grown until the 6
th
 passage in endothelial growth 
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(PromoCell) at 37 °C, in a 5 % CO2 atmosphere; iii) MDA-MB-231 – breast 
adenocarcinoma, obtained from ATCC, cultured in Leibowitz L-15 medium 
supplemented with 10% FBS and antibiotics (100 U ml-1 penicillin G, 100 mg 
ml-1 streptomycin), and grown at 37°C in a free gas exchange with 
atmospheric air. Figure 4-6 shows these three cell line during culture. 
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Figure 4-6. Cultured cells in adhesion 
(A) J-774, (B) HUVECs, and (C) MDA-MB-231 cell line in culture. 
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Cell culturing 
Growing cells requires extreme care in observing standard procedure 
and sterile environment to assure good health, uniformity of responses, and to 
prevent any sort of pollution, i.e. microbial contamination. Handling of any 
cell line therefore must be operated under a sterile biohood with constant 
aspirating air flow; to ensure the work safety for the user, high-efficiency 
particulate absorption (HEPA) filters are required as the air exits the biosafety 
cabinet. Basic sterilization procedures include earlier wiping with 70 % 
ethanol solution on worn safety gloves and working surface, as well as every 
non-sterile object brought inside the hood; in addition the hood surface was 
wiped again after the use and exposed to UV light for a minimum of 20 min to 
totally deplete any presence of bacteria.  
Cells were typically seeded in Petri dishes (3.5, 5, or 10 cm in 
diameter) and stored in incubators when not operated; growing medium is 
replaced on a 2 days basis, or depending on the particular cell line 
requirements. Harvesting method of cells for suspensions or reseeding, i.e. 
when confluent, depends on the cell line. For J-774 macrophages medium was 
removed with a Pasteur pipette and the cells were washed with a small volume 
of DPBS with Ca
2+
 and Mg
2+
; cells were gently scraped from the dish bottom 
and collected in tube. HUVECs and MDA-MB-231 cell were washed in the 
same DPBS and treated with trypsin (PromoCell). Trypsin is used to cleave 
proteins bonding the cells to the dish, in few minutes under incubation; as 
soon as the cells were detached from the dish growing medium in ratio 3:1 
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was added with the purpose of blocking the trypsin function, and the cells 
were collected in tube (Figure 4-7A). 
 
Figure 4-7. Cells harvesting process 
(A) Suspended cells (HUVECs) (B) centrifuged cell pellet before re-
suspension and (C) after. 
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 For both methods, the cells need to be centrifuged (~4 min at 11.2) so 
that the supernatant can be removed and the cell pellet re-suspended in few ml 
of fresh growing medium (Figure 4-7B and C); cells can be reseeded or 
treated in suspensions. To count the cells number, 10 µl of the suspended 
solution are mixed 1:1 with 0.4 % trypan blue solution; 10 µl of the mixture 
are applied to each of the two coverslip edges of a hemocytometer – Hausser 
Scientific. Trypan blue is a diazo dye used as vital stain for a dye exclusion 
method, since it is not absorbed by a viable cell but it traverses a dead cell 
membrane (Figure 4-8). Dead – or dying – cells are therefore colored in blue, 
whilst live cells are easily distinguishable under the microscope. The average 
number of living cells on 4 quadrants is used to calculate the cell 
concentration is suspension, based on the formula: 
000'10 factordilutioncountcellaverageconc  [cell ml
-1
] (4-1) 
Where the dilution factor is 2. All the solution used are stored following 
vendor instruction and warmed in water bath at 37 °C before use. 
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Figure 4-8. Cell counting 
Hemocytometer counting area and magnification of the bottom-right quadrant. 
Detail of living (white) and dead (dark) cells. Arrows point to some of these as 
example. 
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Viability assay 
MTT viability tests (3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide, from Invitrogen Life Sciences) was used in 
order to assess the toxicity arising from the several particles formulation. Cells 
seeded in 96-well plates were treated with at least five different iron 
concentrations (0, 50, 100, 500, 1000 µM) of iron, for at least 5 replicates; 
then cytotoxicity tests were run at 24, 48, and 72 hrs 5 mg of MTT salts were 
previously dispersed per ml of PBS, and 10 µl of solution added to each well 
and incubated again until the interior of the cells could be seen by microscope 
totally stained in blue (≥2 hrs); plates were then centrifuged at 2000 g for 5 
min in order to completely deposit the hydrophobic salts crystals to the bottom 
of the wells. After removing the medium and replacing it with 100 µl 2-
propanol (from Fisher Scientific, #A416-500) to suspend the crystals, the 
plates were spun for 10 min (300 rpm); absorption can be read (Synergy H4 
Hybrid Multi-Mode Microplate Reader, from BioTek Instruments, Inc.) at 
both 540 and 690 nm wavelength. Reading values from the second wavelength 
were subtracted from the first one to clear background noise. Final average 
and standard deviation of viability values were calculated over the five 
replications after blank subtraction. Control in pure medium was taken as 
reference at 100 %. 
  
  
109 
 
 A novel class of magnetic nanoconstructs 
4.1.4. Results 
PLGA based constructs 
Investigation on the confinement effects of SPIOs were originally 
developed with two particles formulations based on a polymeric matrix of 
PLGA, represented in Figure 4-9: 
(i) Hybrid NanoParticles (HNPs) [132];  
(ii) Discoidal Polymeric Nano-constructs (DPNs) [130]. 
 
 
Figure 4-9 Hybrids NanoParticles (HNPs) and Discoidal Polymeric 
Nanoconstructs (DPNs) structure. 
Shown in the figure are the inner structures of both HNPs (left) and DPNs 
(right) used for preliminary tests. Both present a polymeric matrix in PLGA, 
loaded with several sizes of IOs and Rhodamine B fluorescent dye. HNP core 
is stabilized by a corona of PEGylated lipids, which permit a better solubility 
in hydrophilic media. Diameters are ~80 nm and ~1000 nm respectively; 
DPNs height is 500 nm. 
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HNPs are nano-metric assemblies based on a matrix of PLGA with a 
PEGylated lipid corona. The polymeric core is highly porous and allows for 
inner loading of third components, as can be drugs or, in this case, 17 nm 
spherical IO particles; the high porosity is also critical for T2 contrast 
performances. The aim of the PEGylated lipid corona surrounding the polymer 
is to stabilize the structure and provide a higher fluidity in hydrophilic 
suspension. Together with the SPIOs, HNPs were loaded with Rodhamine B 
as red fluorescent staining. Direct laser measurements (DLS) indicate a well 
monodispersed population, PDI = 0.198 ± 0.008, and hydrodynamic radius of 
78.8 ± 6.9 nm.  
DPNs are PLGA-based discoidal nano-constructs with highly 
homogeneous sizes of 1 µm diameter and 500 nm height, due to their top-
down method of fabrication. PLGA was directly functionalized with PEG 
chains, which highly increase water affinity. Similarly to HNPs, the porous 
structure of PLGA permits loading with several components and water 
diffusivity for enhanced contrast imaging properties; in addition, their bigger 
size assures higher loading capacity therefore versatility of application. AFM 
measurement (Figure 4-10) reports 968 nm in diameter and 509 nm in height, 
and zeta-potential is quantified to be -19 ± 8 mV. 
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Figure 4-10. Physical characterization of DPNs. 
(A) SEM image original Si template reporting a width of 1.28 µm and a height 
of 518.9 nm. (B) Fluorescence microscopy of the particle inside PVA template 
as for before the harvesting, and inset of a reproduction of the PDMS 
complementary template. (C) AFM image indicating a diameter of 968 nm, 
and a height of 509 nm. (D) SEM image showing the high uniformity of 
DPNs. A high resolution image of a single particle is reported in the inset. 
(Source: Key, J., Aryal, S., Gentile, F., Ananta, J. S., Zhong, M., Landis, M. 
D., Decuzzi P.; Biomaterials, 2013 Vol. 34 Num 21) 
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MNFs: physico-chemical characterization 
Last, a third formulation named magnetic nanoflakes was developed 
with a polymeric core of chitosan. The synthesis procedure was defined 
through a systematic investigation aimed to refine average beads size, 
population homogeneity, and magnetic core encapsulation. The final protocol, 
deeply described in paragraph 4.1.1, consists in an emulsion technique where 
few tens of  22 nm hydrophobic NCs are closely joined together by deoxy 
acid-modified chitosan (deoxy-chitosan), and then stabilized by a lipid 
monolayer and PEG chains. A schematic representation of the MNF is shown 
in Figure 4-11A.  
The MNF stability and monodispersity were determined up to 7 days 
using standard DLS analysis. The data of Figure 4-11B show an average 
hydrodynamic diameter of 156 ± 3.6 nm and a polydispersity index (PDI) of  
0.2 throughout the 7 days. TEM images of the NCs used for the formation of 
the magnetic nanoflakes are presented in Figure 4-11C, where the image in 
the right-top inset clearly demonstrates an edge size of ~22 nm. Electron 
micrographs of the whole nanoconstruct are presented in Figure 4-11D, F. 
These micrographs provide a diameter of the MNFs of ~140 nm, under dry 
conditions. Also, the SEM and TEM images show the spatial organization of 
the NCs within the chitosan matrix which resembles to that of the unpopped 
pop-corn; this inspired the name for these nano-constructs. In the synthesis of 
the MNFs, the iron yielding is 50 ± 15 % which was calculated as the ratio 
between the initial and final mass of iron estimated via ICP-OES. The zeta-
potential of the MNFs was measured to be 37.9 ± 2.7 mV, lower than that 
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measured for chitosan alone (~46 mV). The reduction in surface electrostatic 
charge has to be associated with the presence of the lipid and PEG-COOH 
corona which stabilizes the whole nanoconstruct. 
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Figure 4-11. Physico-chemical properties of Magnetic NanoFlakes 
(MNFs). 
(A) Schematic representation of a MNF; (B) Stability test over time in PBS 
solution (av. diameter = 156 ± 3.6 nm; av. PDI = 0.2 ± 0.007); (C) TEM 
image of the nanocubes (NCs) used during the synthesis. The NC edge length 
is 22 nm (inset); (D) SEM image of the MNFs; (E, F) TEM and SEM images 
of the MNFs showing the NCs confined within the polymeric matrix. MNFs 
appear as spherical nanoconstructs with an average size of  140 nm. 
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Cytotoxicity 
The cytotoxic behavior of the magnetic nanoflakes was characterized 
on endothelial cells (HUVECs), which represent the first cell type encountered 
by nanoconstructs upon system injection, and a breast cancer cell line (MDA-
MB-231). Different concentrations of MNFs were incubated with the cells and 
cell viability was monitored at 24, 48 and 72h post incubation using a MTT 
assay.  
As shown in Figure 4-12, during the first day of incubation, no loss in 
viability is observed for the HUVECs up to concentrations of 500 µM. At 
1,000 µM, the HUVEC viability dropped to 70%. Similarly, some negligible 
toxicity (i.e. viability < 90%) is detected at concentrations larger than 100 µM 
for the second and third days of analysis. A similar trend is observed for the 
MDA-MB-231, but the overall toxicity is lower than what documented for the 
HUVECs. Cancer cell viability is higher than 80% for concentrations of 500 
µM up to 72h. Only at the highest concentration, of 1,000 µM, the cell 
viability of the MDA-MB-231 dropped below 80%. 
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Figure 4-12. Cytotoxicity of MNFs. 
To assess the toxic effects of bare MNFs on both healthy and tumor cells, 
MTT viability test was performed on (A) HUVECs and (B) breast cancer 
MDB-MB-231 cell lines up to three days of incubation in normal conditions 
and with no exposure to magnetic field. Cell viability was measured at three 
different time points and four different MNF concentrations, up to a particle 
concentration in the culture medium of 1mM of iron. HUVECs cells, well-
known for their high sensitivity, show a good survival rate up to 80 % viability 
at 72 hr; as well, MDA-MB-231 cancer cells show a similar trend, with a 
slightly higher overall viability. 
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 Magnetic dragging 4.2. 
4.2.1. Microfluidic experiments 
Fluorescence microscope 
The observation of micro- and nano- scale was possible thanks to an 
inverted fluorescence microscope – Ti-Eclipse, Nikon (Figure 4-13A). 
Particles, static or in motion, were seen using dry microscope objectives, 
magnifications of 10x, 20x and 40x; the microscope mounts fluorescent filters 
for blue (DAPI) and red (FITC) transmitters. These components allowed for a 
clear view on particles down to 200 nm in size. Dynamic acquisition of images 
was possible because of Andor’s LucaEM S camera; it utilizes a 658 × 496 
“interline frame transfer” EMCCD sensor to acquire the region of interest 
(ROI). A highly informative real time sequence of events could further be 
generated by means of an automatic shutter on the transmitted light path, 
which alternates the acquisition of the desired ROI in bright-field and 
fluorescence mode with duty cycle on the orders of tenths of a second. The 
shutter operation, all the acquisition, and analyses were managed by the 
dedicated software NIS-Elements, from the same microscope producer.  
Flow chamber 
The same shear rate and flow velocity the particles would experience 
in a vein were reproduced using a commercially available flow-chamber 
(GlicoTech), shown in Figure 4-13B and C. This is a microfluidic device 
composed of a discoidal body, 3.5 cm diameter × 1 cm height, in casted 
acrylic; two inlet/outlet tubes provide for the flow, and a third one is 
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connected to an annular chamber for vacuum. The 20 mm long channel is 
created applying on of the silicon rubber gaskets, provided in several 
combination of width (0.25, 0.5, 1 cm) and thickness (0.005 and 0.01 in), and 
then a glass coverslip. Vacuum grease spread between the gasket and the 
coverslip enhances the adhesion between these and the three components, 
which are firmly kept together by vacuum. For the flow, a syringe containing 
the sample with the desired concentration was mounted on syringe pump – 
Pump 33, Harvard Apparatus – and connected to the flow chamber inlet; it 
provides a constant flow rate from 0.0004 µl/hr up to a maximum of 106.6 
ml/min, and can host syringe sizes from 0.5 µl up to 140 ml. Using the 
inverted microscope described above, ROI of 658 × 496 px are captured over 
the channel with the higher possible acquisition rate, in relation with the 
particular exposure time required by the sample for an optimal visualization.  
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Figure 4-13. Microfluidic apparatus 
(A) Fluorescence inverted microscope with the syringe pump. (B) The flow 
chamber mounted on the microscope. (C) Back of the flow chamber with the 
magnet mounted on the channel side 
Static and in-flow particles dragging 
The capacity to respond at an external static magnetic field attraction was 
investigated in both cases of resting and dynamic fluids. The fluorescence 
microscope previously described was employed to record in real time the 
particles, nanoconstructs, or IOs loaded cells dragged using 2 discoidal 
magnets (Figure 4-14) purchased by Apex Magnets: 
a) 12.7 mm × 1.6 mm height diameter, grade N48 – able to express a 
magnetic pull force of 35.6 N at an L50 distance of 0.33 mm from steel 
and 7.9 N at L50 distance of 0.75 mm from a second magnet; 
b) 6.4 mm × 0.8 mm height diameter, grade N52 – able to express a 
magnetic pull force of 9.38 N at an L50 distance of 0.12 mm from steel 
and 1.51 N at L50 distance of 0.42 mm from a second magnet; 
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Figure 4-14. Magnets used for dragging experiments. 
The plots show the pull forces (magnet/steel and magnet/magnet) of the (A) 
12.7 mm and (B) 6,4 mm diameter discoidal magnets used during 
experiments, with images in the insets. 
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In all the experiments, except for a few cases in which was not possible 
or not convenient for the researched interrogation, the samples were prepared 
such to present a red fluorescence, and the microscope shutter set to switch 
between bright field and FITC filter. In this way recorded movies show 
superimposition of the two. Red fluorescence was provided by Rhodamine B 
dye – L-α-Phosphatidylethanolamine-N-(lissamine rhodamine B sulfonyl), 
Avanti Polar Lipids, Inc.  
For static dragging tests a drop of few µl of sample was placed on a 
glass coverslip edge and the microscope field of view is pointed to the drop 
edge closer to the magnet. The focus was set case-by-case such to better 
distinguish the highest number of particles possible, eventually close to half 
the height of the drop; nevertheless, due to its small height, most of the 
particles are still recognizable even if out of focus. The software started 
recording and, following, the magnet (a) was approached to the sample; 
movies were recorded at 1, 3 and 6 mm distance from the drop edge, for the 
time required by each experiment (but always ≥ 2 min).  
For dynamic dragging tests, meaning a quantification of the particles 
drifting from the blood flow direction towards a static magnet and their local 
accumulation, the flow chamber from GlicoTech previously described was 
mounted on the microscope platform with magnet (b) attached on its bottom 
(Figure 4-15). In this system a laminar flow with parabolic velocity profile 
was established in the between the two parallel walls. The channel sizes 
(height h and width w) and the flow rate Q provided by the syringe pump are 
chosen such to satisfy the equation: 
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wh
Q
S
2
6  [s
-1
] (4-2) 
for shear rate S values relevant to physiological condition of healthy tissues 
(100 - 200 s
-1
) or sub-physiological ones found in tumoral vasculature (10 - 
100 s
-1
) [133]. Magnet was positioned halfway in the channel on one side, in 
order to witness the particle drifting from the horizontal flow towards the 
magnet.  
 
 
Figure 4-15. Flow chamber channel with magnet position. 
Representation of the channel inside the flow chamber and with the magnet 
position during dragging experiments. The magnet is poses halfway of the 
channel, on the side 
 
The camera started recording right after the flow completely fills the 
channel. For the drifting quantification was then measured the angle of particle 
trajectory versus the distance from the magnet. The preferential accumulation 
of particles required an earlier preparation step: a sample drop is left dry on 
the coverslip with a magnet underneath before mounting on the flow chamber. 
Once the whole system is mounted, the deposited particles will eventually get 
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magnetized by the external magnetic field, producing a local magnetic 
gradient in their proximities. This cooperative effect was quantified by the 
increasing area of the originally deposited clusters over time. All the images 
captured were processed using Image-J software (Figure 4-16). 
 
 
Figure 4-16. Imaging process of the flow chamber aggregates. 
(A) Fluorescence microscope image of deposited aggregates of DPNs 
particles. (B) Outlines of the aggregates processed by Image J software during 
the area quantification. 
 
Imaging process 
Every post processing of images, for size distribution or intensity 
fluorescence estimation, were executed by ImageJ software, developed for 
scientific purposes at the American National Institutes of Health (NIH), 
Research Center, in Maryland. 
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4.2.2. Results 
HNPs were employed for static dragging studies of macrophages upon 
internalization. J-774 macrophages cell line is incubated for 6 hrs. with 
HNPs+17nm IOs, iron concentration of 0.9 mM. After washing and re-
suspension, J-774 are dropped on a glass coverslip and mounted on a 
fluorescence inverted microscope (see paragraph 4.2.1). Superposition of 
bright-field and FITC fluorescence images in Figure 4-17 demonstrates a 
clear internalization of the HNP+17 nm IOs. In every panel the totality of the 
fluorescent signal is co-localized within the macrophages; instead, no signal 
can be found on the outside. At time t = 0, the magnet (a) described in section 
4.2.1 was placed ~1 mm away from the drop edge, in correspondence to the 
bottom side of the figure. Figure 4-17 shows frames from the recorded video 
of the experiment up to 20 sec at intervals of 4 sec. In this sequence, cells 
quickly accumulates on the edge next to the magnet, pushed by the magnetic 
particles internalized; after 15 sec the only cells not moving towards the 
magnet are those already attached to the coverslip. 
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Figure 4-17. Dragging of J-774 macrophages loaded with Hybrids 
NanoParticles (HNPs) + 17 nm IOs.  
J-774 macrophages were incubated 6 hrs. with 17 nm IOs loaded HNPs. Iron 
concentration in grown medium was 0.9 mM iron. Particles are stained red 
dye. Few µl of re-suspended macrophages were dropt on a glass coverslip and 
a magnet placed next. Movie was recorded in bright and red fluorescence 
fields. In the first frame at t = 0 is clearly visible the solo localization of the 
HNPs inside the cell area. Most of the cells were then attracted towards the 
magnet in the bottom of the visible area within the first 10 sec. 
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Similarly, few µl of suspended DPNs+5 nm SPIOs were dropped on 
the flow-chamber coverslip previously placed on a magnet, and left dry so as 
to create pre-existing, deposited aggregates. During control experiments in 
flow chamber without magnet (Figure 4-18A), these aggregates deposited 
beforehand decrease in their net intensity and, in some cases, also in area; per 
counter, application of magnet (b) (paragraph 4.2.1) on the chamber bottom 
produces an increase of both agglomerates area and intensity (Figure 4-18B). 
Most importantly, the incoming particles do not distribute randomly over the 
visible area, rather selectively deposit on pre-existing aggregates. Figure 
4-18C reports the increase rate of the overall area covered by the original 
aggregates. After ~5 min flow, deposited MNFs cover a total area 4.1 times 
bigger than the area covered at t = 0.  
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Figure 4-18. In flow accumulation experiments 
(A) Two frame from the control experiment movie, with pre-deposited DPNs 
on the bottom floor and no magnet. Without a magnet most of the particles are 
carried away by the flow. Area and intensity are hence reduced. (B) From in-
flow experiment with the magnet, progressive accumulation is appreciable in 
the reported frame at t = 0, 0:30, 2:00, and 4:30. Both size and fluorescence 
intensity grows in time. (C) Few aggregates are taken as reference and their 
area monitored over 5 min flow. The charts shows continuous increase of their 
total area, up till 4.1-fold compare to t = 0. 
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The response of MNFs to static fields was investigated by exposing a 
MNF solution under flow to magnet (a), as depicted schematically in Figure 
4-19A. The flow rate and the chamber geometry were selected to impose a 
fixed, physiologically-relevant wall shear rate of 100 s
-1 
[134]. As usual, the 
MNFs were labeled with rhodamine B and appeared as red dots under a 
fluorescent microscope. For undisturbed conditions, the MNFs are transported 
downstream by the flow following the stream lines, whereas in the presence of 
the external magnet, the MNFs were observed to drift laterally across the 
stream lines and accumulate next to the magnet forming a dense red corona, as 
shown in Figure 4-19B. The surface density of the MNFs accumulating 
around the magnet is shown in Figure 4-19C and is presented in terms of 
percentage of surface covered as a function of the distance y from the magnet 
surface. In proximity of the magnet, the deposited MNFs cover up to 60% of 
the available surface. Indeed, as the separation distance from the magnet 
increases, the surface density of deposited MNFs reduces being  5 % at  1.2 
mm away. Note that the width of the parallel plate flow chamber is 10.0 mm, 
in the present configuration.  
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Figure 4-19. Remote guidance of the Magnetic NanoFlakes (MNFs) 
(A) Schematic representation of the parallel plate flow chamber used for the 
experiments. (B) MNFs are stained with red dye to allow for a clear visibility 
at low magnification. Three individual images show the path of two particles 
in flow (yellow and white arrow) at three consecutive time points; also a 
fluorescent annulus is well recognizable around the magnet edge by the 
deposited MNFs after the experiment. (C) Percentage of the area covered by 
the deposited nanoparticles is plotted as a function of the separation distance 
from the magnet edge. Up to 5% of the area is still covered by MNFs at  1 
mm away from the magnet. 
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The dynamics of accumulation can also be appreciated in the 
brightfield image in Figure 4-20, clearly showing the lateral drift of MNFs. 
As for DPNs, even in absence of pre-formed agglomerate the first clusters 
deposited on the channel floor become seeds for the growth of needle-like 
structures; acting as a local magnet, these attract the MNFs floating in their 
proximity which eventually become part of a bigger aggregate. The growing 
direction at 70 ° from the horizontal flow points towards the magnet, 
confirming once more the particles drift. 
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Figure 4-20. Accumulation of MNFs at the bottom of the flow chamber 
during flow in physiological condition. 
 The bright-field images shown accumulation on the channel floor up to a 
distance of ~1 mm from the magnet edge, marked by the dashed line. The flow 
in the channel is set as to reproduce the same physiological condition of blood 
flow in a healthy tissue (shear rate 100 s
-1
), which is typically faster than the 
blood flow in tumor vasculature (shear rate 20 - 100 s
-1
). Attracted by the 
magnet, MNFs considerably drift away from the horizontal flow direction and 
tend to accumulate on the bottom of the channel, covering ~5 % to 60 % of the 
visible area as the distance to the magnet reduces from 1.2 mm to 0 mm. It can 
be appreciated the local accumulation of several particles in bigger structure, 
due to mutual attraction from the local magnetization field of the MNFs. 
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 Relaxometric properties 4.3. 
4.3.1. Relaxivity characterization 
In order to assess the particles capacity to shorten longitudinal and 
transversal relaxation time T1 and T2, it was used a bench-top relaxometer 
(mq60 “The Minispec” – Bruker Corporation) operating at 1.41 T and 37 ºC. 
For each sample, high dilutions were required to reach required iron 
concentrations below 3 µMol (~1.7·10
-4
 mg ml
-1
); each dilutions are in 
triplicate, so as to minimize approximation errors. Longitudinal and 
transversal relaxation r1 and r2 are then calculated as: 
 Fe
TT
r
w
ii
i 








11
 [mM
-1
 s
-1
] (4-3) 
In which Ti
w
 represents the proton relaxation of pure water, and Ti is for the 
sample. 
 
4.3.2. Results 
The local confinement of IOs in a porous structure as a polymer matrix 
has been proven to enhance the transversal relaxivity provided by a single 
particle. In [130], Key and co-workers using DPNs show a remarkable r2 
relaxivity increase of ~4.6 times if compared to the single particles. In fact, 
commercially available, hydrophilic 5 nm IOs had shown an intrinsic 
transversal relaxivity of 107 ± 24 mM
-1
 s
-1
, whereas 1 µm DPNs loaded with 
the same particles reached values of 495 ± 36 mM
-1
 s
-1
. In comparison, the low 
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r1 for free (8 ± 1 mM
-1
 s
-1
) and constrained (6 mM
-1
 s
-1
) iron oxides confirms 
their quality as T2 contrast agents. 
Similarly, MNFs were also characterized for their quality as T1 and T2 
contrast agents. Compared to pure water, relaxometric measurements report a 
ΔT1 = 473 ± 47.1 s and a ΔT2 = 2242 ± 49 s; these correspond to a longitudinal 
relaxivity r1 of 4.98 ± 0.58 (mM s)
-1
and a transversal relaxivity r2 of 475 ± 28 
(mM s)
-1
. The iron concentration is measured to be 0.15 µg ml
-1
, via ICP-OES. 
Note that since the individual NCs are coated with a single layer of oleic acid 
(i.e. are hydrophobic) and the relaxometric properties depend on the surface 
chemistry of the nanoparticles, the r2 for the individual NCs could not be 
estimated for a direct comparison. 
Figure 4-21 compares the relaxometric performances of the different 
particles; it is interesting to note the capacity of MNFs, which are ~140 nm in 
diameters, to perform comparably to DPNs, which are several times bigger 
(~1 μm). 
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Figure 4-21. Relaxometry performance of free Iron Oxides (IOs) free and 
loaded inside Discoidal Polymeric Nanoconstructs, and Magnetic 
NanoFlakes (MNFs).  
The bar chart shows the efficacy of local confinement of the SPIOs inside a 
bigger construct. In the latter, in fact, an enhancement of ~4.6 times compared 
to the case of free particles is achieved. 5 nm iron oxides show an intrinsic 
transversal relaxivity of 107 ± 24 mM
-1
 s
-1
, whereas 1 µm DPNs loaded with 
the same particles reach values of 495 ± 36 mM
-1
 s
-1
. In comparison, the low 
r1 for free (8 ± 1 mM
-1
 s
-1
) and constrained (6 mM
-1
 s
-1
) iron oxides confirms 
their quality as T2 contrast agents. 
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 Thermal ablation properties: in-vitro and 4.4. 
preliminary in-vivo experiments 
In-vitro characterizations of the heating performances for the synthesized 
nanoconstructs followed procedures previously described for the scope. A 
preliminary work on animal model bearing a breast tumor was developed 
based on the results discussed in the previous chapters. 
 
4.4.1. Animal studies 
Tumor model 
All animal protocols was reviewed and approved by Animal Protocol 
Review Committee at the The Methodist Hospital Research Institute, Houston, 
TX. The same institution provided the mouse for the experiment. Tumor 
model was initially generated by xenograft transplantation of patient human 
breast cancer tumor MC1 in the #4 mammary gland and grown for about 1 
month prior treatment, to a size of ~500 mm
3
 
Particles injection 
The tumor was treated with MNFs a 2 hrs ahead the magnetic 
hyperthermia treatment, such to allow the particles to permeate from the 
injection site to its proximities. From 9 to 10 injections, for a total of 100 µl, 
were performed around the whole volume of the tumor. Iron concentration in 
the sample was ~2.6 mg ml
-1
. The same procedure was repeated on day 1 and 
day 9 of the treatment. 
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Hyperthermia treatment 
On the days of injections, and the following 2 days, the mouse was 
exposed for 30 min to alternated magnetic fields at a frequency of 298.5 kHz. 
The field strength was modulated to 35 kA m
-1
 for the first 20 min, than raised 
to 45 kA m
-1 
for the remaining 10 min of the treatment. 
 
4.4.2. In-vitro characterization 
The magnetization properties of the MNFs are presented in Figure 4-22. 
Using the SQUID magnetometer previously described (paragraph 3.1), the 
magnetization Ms of the nanoconstructs was measured as a function of the 
external applied field H. The data of Figure 4-22A demonstrate the lack of 
any hysteresis loop and a magnetization saturation of ~80 emu g
-1
, which is 
comparable with the values obtained in literature. However, with a 
susceptibility of ~0.21, the present MNFs tend to have a lower rate of 
magnetization at low fields if compared with the NCs synthesized in [63, 123, 
135]. 
The ablation properties of the MNFs were derived by exposing the 
nanoconstructs to an alternating magnetic field (AMF) and registering the 
temperature variation of the sample over time. In particular, a vial containing 
an aqueous solution (0.6 ml) of magnetic nanoflakes (0.76 mg ml
-1
) was 
exposed to an AMF (512 kHz, 10 kA m
-1
), showing an increase in temperature 
of ~6 °C within 30 min of treatment (Figure 4-22B). The experiment was 
repeated 5 times with very small variations in temperature.  
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Following the protocols described in 3.3.2, from the temperature-time 
curve the specific absorption rate (SAR) of the MNFs is quantified to be 73.8 ± 
2.3 W g
-1
. This value is ~60 time larger than the SAR measured for the 
individual NCs in ethanol (tested at 0.94 mg ml
-1
), which is measured to be 
1.25 ± 0.12 W g
-1
. The corresponding ILP values are 0.024 ± 0.002·10
-9
 (m
2
 s
-1
 
A
-1
)
2
 and 1.44 ± 0.045 ·10
-9
 (m
2
 s
-1
 A
-1
)
2
 for singles NCs and MNFs, 
respectively. These data are presented in the bar chart of Figure 4-22C. The 
significant enhancement in the heating performance should be attributed to the 
geometrical confinement of the NCs within the polymeric matrix. 
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Figure 4-22. Magnetic properties of the Magnetic NanoFlakes (MNFs) 
(A) SQUID analysis of cycle magnetization shows the lack of hysteresis loop 
and a magnetization saturation of  80 emu g-1. (B) Temperature increase over 
time for two 0.6 ml solutions of MNFs (0.76 mg ml
-1
) and NCs (0.94 mg ml
-1
) 
exposed to an alternating magnetic field (512 kHz / 10 kA m
-1
 AMF) for 30 
min; solid black line indicates the average over 5 repetitions, and the grey 
shadow the standard deviation.(C) Bar chart comparing the hyperthermia 
related values of single NCs / MNFs nanoconstruct: SAR = 1.25 ± 0.12 / 73.8 
± 2.3 W g
-1
 ; ILP = 0.024 ± 0.002·10
-9
 / 1.44 ± 0.045 ·10
-9
 (m
2
 s
-1
 A
-1
)
2
. Note 
that encapsulated nanocubes (NCs) in MNFs show performances as  60 times 
larger than that free ones.  
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4.4.3. Preliminary in-vivo test on small animal 
Preliminary work on the tumoritopic efficacy of MNFs was conducted 
on a small animal subject. The mouse was injected in the #4 mammary gland 
with a human MC1 patient-derived breast tumor; the tumor was allowed to 
grow for about 1 month before starting the treatment. Several 10 µl injections 
of MNFs were performed around the whole tumor volume to better distribute 
the particles. Based on the design map in Figure 3-15 and on Equation (3-3), 
with H0 = 35 kA m
-1
 and f = 300 kHz, the concentration of MNFs required to 
reach an efficient hyperthermia (42 °C) is calculated to be 1.9 mg ml
-1
, whilst 
an ablation treatment would requires (50 °C) is 5.1 mg ml
-1
. Hence, MNFs 
were injected at an iron concentration of ~2.6 mg ml
-1
, also considering tissues 
permeation of the fluid upon injection. 
After about 2 hrs following the injections, the mouse was placed inside 
the high power hyperthermia apparatus described in section 3.2.3, with the 
tumor at the center of the coil (Figure 4-23A and B). Hyperthermia was 
performed at ~35 kA m
-1
 for about 20 min; then the power was increased up to 
45 kA m
-1
 in the last 10 min; frequency of the AMF was kept stable at ~300 
kHz. Exposure to magnetic field was repeated for 3 consecutive days; particles 
injection and treatment were identically repeated a week after the first 
injection. The mouse and its tumor were monitored for about 4 weeks, and 
then sacrificed. 
Temperature increase of the tumor is reported in Figure 4-23C. The 
temperature recorded by the nIR camera reaches a first equilibrium around 
36.5 °C after ~10 min of exposure at 35 kA m
-1
; instead, a second plateau is 
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still not seen 10 min after increasing the field to 45 kA m
-1
. The maximum 
temperature reached within the 30 min of exposure is 42.9 °C, in the two 
points indicated by the arrows in Figure 4-23A and B. These points present a 
minor quantity of hairs compared to the rest of the tumor area, which 
definitely affect the camera reading. Hence, it can be deducted that the overall 
area of the tumor reaches a higher temperature than what actually recorded; 
also, most probably the inner volume of the tumor reaches a temperature few 
degrees higher than the recorded 36.5 or 43 °C. 
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Figure 4-23. Tumor exposure to magnetic field. 
The mouse was placed such that tumor can be at the center of the coil 
developing the magnetic field. The dashed line highlights the tumor in the 
visible-light picture (A) and in the infra-red picture (B); the arrows points to 
the same spots in both the pictures, which results in the highest temperature 
(~43 °C) during the whole treatment. These have few hairs compared to the 
rest of the tumor, which can explain the higher temperature detected; at the 
same time this suggests the inner temperature of the tumor is actually higher 
then what indicated by the camera; (C) Temperature profile of the tumor over 
20 min of exposure at ~35 kA m
-1
 and then ~45 kA m
-1
 for the remaining 10 
min. At the 30
th
 minute of exposure the temperature did not reach equilibrium 
yet. 
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Before the treatment the tumor was measured to be ~1.4 cm in length 
and 1.1 cm in width (see Figure 4-24). For the first three days during 
hyperthermia treatments the tumor length seen a small reduction, but its width 
increased. During the following days without further treatments, both width 
and length were stable around 1.25 cm and neither increase nor reduction can 
be appreciated. A second injection and second cycle of exposures to AMF had 
similar results showing neither increase nor reduction of tumor size. It was 
also observed that on day 1 the tumor felt stiff on touch, whilst on day 3 it was 
considerably softer. This can indicate a decreasing volume of necrotic tissues 
as results of the treatment. The tumor remained stable up to the end of the 3
rd
 
week. On the 10
th
 days from the last treatment (day 21) the tumor started to 
grow again and the animal was sacrificed on the 16
th
 day (day 27).  
  
143 
 
 A novel class of magnetic nanoconstructs 
 
Figure 4-24. Tumor size during preliminary hyperthermia treatment with 
MNFs. 
(A) The mouse on day 1. MC1 patient-derived breast tumor xenograft were 
grown on the mouse #4 mammary gland (orthotropic); its sizes are measured 
on the white (width) and black (length) dashed line reported. (B) The mouse is 
injected with MNFs on day 1 and day 9, and subdued hyperthermia treatment 
at ~40 kA m
-1
 and 300 kHz on each injection day and following for 2 days. 
Measured length of the tumor starts at 1.4 cm and is slightly decreasing to 1.25 
cm in the first five days; in the same period the width increases from 1.1 cm to 
1.25 cm and both reach a steady state after about a week. On average, the 
tumor shows no further increase during the treatment period and both the sizes 
oscillate between 1.2 and 1.25 cm till the third week. 10 days after not 
receiving treatments the tumor started to grown again. 
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 Comparison with conventional SPIOs and 4.5. 
iron oxide nanocubes 
Dragging 
Polymeric nanoconstructs are exploited to maximize the iron density in 
a defined geometry, and test the accumulation potential in flow conditions; a 
second hypothesis of this study was that the generated magnetization field of 
magnetic aggregate is capable to capture the particles flowing in its 
proximities. 
Experiments performed in physiological relevant conditions 
(microfluidic flow channel with shear rate S = 100 s
-1
) demonstrate a 
cooperative accumulation of DPNs and MNFs particles. Next to the magnet, 
externally applied to the region of interest, local accumulation of polymer 
based nanoconstructs increases at least 12 times. It is worth to be noted that 
accumulation rates would be further increased in tumors, due to the lower 
shear rate of a typical neoplastic vasculature. At the author knowledge, similar 
improvement in local accumulation has not yet been demonstrated for 
application of the kind.  
Nanoparticles injected through systemic administration typically result 
in excessive accumulations in liver or spleen, and a minimal percentage make 
its way to the tumor [97]; this corresponds to a higher intoxication for the 
patient and a huge loss of curative efficacy. The results achieved here are a 
promising first step towards the leveraging of this unbalance relationship. 
Additionally, in a preliminary study IOs loaded HNPs attracted by the 
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magnetic field successfully managed to move J-774 macrophages that have 
these particles internalized.  
Relaxometry 
The group of Hyeon [135] has shown that single, 22 nm NCs can 
provide transversal relaxivities r2 as high as 761 (mM s)
-1 
(Figure 4-25A). 
Importantly, this large relaxivity value has been never demonstrated for 
clustered NCs. Here, polymeric architectures are exploited for their capacity to 
assure the water diffusivity with the inner IOs core. 1 μm sized discoidal 
particles were able to enhance the relaxometric property of the single spherical 
particle entrapped in their core; similar values of transversal relaxivity r2 are 
also achieved with much smaller nanoconstructs (~140 nm) starting from 
cubic shaped iron oxides. This shows that remarkably high relaxivities can 
also be achieved by forming proper clusters of NCs.  
Both DPNs and MNFs shows a transversal relaxivities r2 around 485 
mM
-1
 s
-1
, which is only 40% smaller than what been measured by Hyeon for 
individual NCs. This value is significantly larger than that offered by other 
IOs and IO-based systems, such as the FIONs (r2 = 324 mM
-1
 s
-1
), MPIOs (r2 
= 169 mM
-1
 s
-1
), and the Feridex nanoparticle (r2 = 133 mM
-1
 s
-1
). This 
transversal relaxivity is also larger than that documented for clusters generated 
with conventional spherical IOs. For instance, the group of Simard had 
demonstrated a r2 up to 400 mM
-1
 s
-1 
[115]; whereas the group of Morales had 
obtained r2 up to  300 mM
-1
 s
-1
[116]. It is then possible that even larger 
relaxivities can be achieved by packing NCs in the same polymeric matrix. 
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Heating 
The SAR is a dosimetric quantity that has been introduced for assessing 
the amount of absorbed radiation power by unit mass of particle. It depends on 
the operating conditions of the AMF apparatus used for stimulating the IOs, 
namely the frequency f and field strength H0. SAR is proportional to H0
2
·f 
therefore a meaningful comparison for the ablation properties among different 
nanoparticles can only be performed if the individual SAR are normalized by 
H0
2
·f. Based on these considerations, the intrinsic loss power (ILP) has been 
introduced as more efficient index to compare particles tested in different 
conditions (section 2.5). 
Consequently, the SAR of  2’500 W g-1 reported by 
Pellegrino&Gazeau group [63] (f = 520 kHz and H0 = 29 kAm
-1
) correspond 
to an ILP of  5.6·10-9(m2 s-1 A-1)-2. Similarly, the ILP values for 5 nm SPIOs 
and the Feridex nanoparticles would be equal to  0.39·10-9 and ~0.17·10-9 (m2 
s
-1
 A
-1
)
-2
, respectively. The magnetic nanoflakes here developed present a SAR 
of 1.44 ± 0.045 ·10
-9
 W g
-1
. Although the ILP of the MNFs is 4 times lower 
than that measured by Pellegrino&Gazeau’s group, it still results to be 4 to 15 
times larger than the ILP depicted for more conventional systems (see Table 
2-2 and Figure 2-6). The difference in ILP between the MNFs and the 
Pellegrino&Gazeau’s NCs can be attributed to the different magnetic behavior 
of the individual NCs. In particular, the magnetic susceptibility of the 
Pellegrino&Gazeau’s NCs is at least two times larger than that of the NCs 
used here, and of all other IO formulations (Figure 4-25B). The bar chart also 
confirms that ILP and magnetic susceptibility are directly related. Since the 
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ILP of the MNFs is 60 times larger than that of the oleic acid-coated NCs 
(0.024 ± 0.002 ·10
-9
 (m
2
 s
-1
 A
-1
)
2
), it is reasonable to speculate that even larger 
ILP could be reached for the MNFs by confining NCs exhibiting higher 
magnetic susceptibility. 
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Figure 4-25. Polymeric particles performances compared to literature. 
(A) Transversal relaxivity r2 of the MNFs and DPNs compared to other iron 
oxide nanocubes and nanoparticles presented in the open literature. (B) 
Comparison of the intrinsic loss power (bar chart) and the magnetic 
susceptibility (crosses) between MNFs and the best performing IOs nanocubes 
reported in literature. 
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Summarizing, the presented data demonstrate that a construct highly 
performing in several fields can be obtained with a properly designed 
nanoconstruct based on superparamagnetic nanoparticles. In particular, that 
newly synthesized magnetic nanoflakes can combine together: (i) a 
remarkably high relaxivity (475 ± 28 (mM s)
-1
); (ii) specific absorption rate 
(73.8 ± 2.3 W g
-1
, at f = 512 kHz and H0 = 10 kAm
-1
): (iii) high local 
accumulatiokon rates next to an applied magnet upon systemic injection (at 
least 12 times). The synthesis of this nano-construct successfully achieved the 
aim of merging together cut-edge performances that cannot be simultaneously 
achieved by using either individual NCs or IO nanospheres. 
Last, a trial experiment for in-vivo hyperthermia was designed based on 
the results achieved in the previous chapters and other investigators 
procedures [49, 136, 137]. The MNFs particles show a superficial maximum 
temperature of 42 °C, still increasing. Despite this value is not enough to 
trigger an efficient treatment, no appreciable tumor grown is noted up to 10 
days after the last treatments, and for a total of 3 weeks; from the 4
th
 week the 
tumor started to grow again with an overall rate of 0.24 mm
3
 per day. As well, 
in the first period the tumor was not decreasing, which suggests an overall 
mild hyperthermia. Based on the design map defined at the end of the previous 
Chapter. 3 and on the linear response theory, the concentration required for 
an effective hyperthermia should be at least 1.9 mg ml
-1
; MNF iron 
concentration upon injection was no more than 2.6 mg ml
-1
, and good chances 
are that actual concentration decreases in the time between injection and the 
treatment, due to tissue permeabilization. This result was therefore expected.  
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 Conclusions and future works 5.
In relation to a rational design of nanoconstructs for thermal treatment, 
definitions of comparative parameters that could be valid in different operative 
conditions were investigated. The available theory for superparamagnetic 
power loss was analyzed on its dependence on applied field, and magnetic 
properties of particles. Intrinsic Loss Power (ILP) is proposed as better 
suitable substitute for the more common Specific Absorption Rate (SAR). This 
choice is then investigated and validated within ranges typical of biomedical 
applications (Figure 2-5). Evaluations of various literature materials also 
confirms the efficiency of ILP in comparing heating performances of different 
particles tested in diverse experimental conditions (Figure 2-6). These 
considerations also indicate a clear decoupling in the design between the 
magnetic field, as hyperthermia generator, and the employed nanodevice, as 
treatment actuator. 
Three commercially available formulations of superparamagnetic iron 
oxide nanoparticles (SPIOs) were characterized for their hyperthermic 
performance using Alternating Magnetic Fields (AMFs) with field strength H0 
ranging from 0.2 - 30 MHz and frequency f ranging from 4 - 10 kA m
-1
, 
respectively. The three formulations had different magnetic core diameters (5, 
7, and 14 nm) and the nanoparticles surfaces were coated with short PEG 
chains. The absolute temperature increase T and specific absorption rate SAR 
were measured under different AMF operating conditions. In the high 
frequency regime (30 MHz) non-specific heating, associated with salts 
dispersed within the sample solution, dominated; a mild SPIO-induced heating 
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is detected only at physiological and supra-physiological salt concentrations ( 
150 mM). At lower frequencies ( 1 MHz) heating is solely generated by the 
relaxation of SPIOs while no heating is measured for control, salt solutions. 
The undesired, non-specific heating generated at high frequency goes in the 
same direction (and suggests explanation) of the well-known limitation for 
f·H0 first proposed by Atkinson [94], in 1984. Still, as stated in the same paper, 
this threshold is more of a general suggestion than a strict limit. Until a 
dedicated investigation clarifies the effective boundaries, this local heating can 
be synergistically exploited to enhance local sensitivity to other treatments. 
A mathematical model, based on the finite element discretization of the 
bio-heat equation, was developed to predict the increase over time of the 
temperature field in a biological tissue. From this, two scaling laws in the form
bSARc
a
MNPMNP
  are derived to identify minimum requirements for local 
hyperthermia (Ttissue> 42 C; a = 1.0616, b = 2.271410
6 
W m
-3
) and thermal 
tissue ablation (Ttissue > 50 C; a = 1.0737, b = 7.156510
6 
W m
-3
). The 
resulting design maps (Figure 3-15) can be used to rationally design 
hyperthermic treatments and select the proper route of administration – 
systemic versus intratumor injection –, which depends on magnetic properties 
and bio-distribution performance of nanoparticles. This map makes a pair 
together with the indications defined by the linear response theory and 
reported in Figure 2-7. These are overall and general comprehensive 
guidelines of the most influencing parameters, and should be used in the 
rational design of an efficient hyperthermic treatment. The guidelines and the 
stated aspects are valid for every superparamagnetic assembly including the 
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SPIOs nanoparticles, but no limited to these. Additionally, based on 
experimental results obtained from in-silico simulations, one could suggest 
that tumor tissue ablation can be feasible also via the systemic administration 
of nanoparticles provided that sufficient local accumulation is met. In order to 
achieve the required quantities, strategies as surface targeting or directed 
magnetic gradient can be employed. As secondary effect this strategy would 
also reduce non-specific bio-distribution and off-target toxicity. 
To fully exploit the intrinsic potential of SPIOs as multifunctional 
nanoparticles, new magnetic nanoconstructs – Magnetic NanoFlakes (MNFs) 
– were derived. By geometrically confining iron oxide nanocubes of 22 nm 
in edge within a polymeric matrix of deoxy-chitosan, MNFs demonstrates 
merged functionality in heating, MRI imaging contrast, and magnetically 
targeted accumulation. Following such a strategy, a remarkably high 
transversal relaxivity (r2 = 475 ± 28 (mM s)
-1
 at 1.41 T) and specific 
absorption rate (SAR = 73.8 ± 2.3 W g
-1
, at f = 512 kHz and H0 = 10 kAm
-1
, 
ILP = 1.44 ± 0.045 ·10
-9
 (m
2
 s
-1
 A
-1
)
2
) are achieved for the same 
nanoconstructs. Preliminary in-vivo study confirmed the generation of mild 
hyperthermia by using MNFs. This result was expected, based on the design 
map shown earlier. 
Significant enhancement in magnetic properties from individual NCs is 
also confirmed resulting from their geometrical confinement within the 
polymeric matrix. In particular, the SAR/ILP of MNFs has a 60-fold increase 
compared to individual NCs (1.25 ± 0.12 W g
-1
/ 0.024 ± 0.002 ·10
-9
 (m
2
 s
-1
 A
-
1
)
2
). The geometrical confinement of NCs exhibit higher magnetic properties, 
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particularly in terms of magnetic susceptibility and saturation that lead to 
higher SAR and r2 values. Also, in physiologically relevant conditions, the 
denser magnetic core improves their local accumulation (~12-fold) compared 
to areas without magnet nearby. Requirements for systemic administration 
with a limited non-specific accumulation seem therefore closer in being 
satisfied. Another interesting aspect is the cooperation function of MNFs in 
recruiting other particles during magnetic accumulation.  
The goal of merging together cutting-edge performances in a single 
nanoconstruct was successfully achieved. The synthesis of this nano-construct 
shows potentials that cannot be met by using either individual iron oxide nano-
cubes or -spheres. Nevertheless it represents a first step towards the realization 
of nanoconstructs with superior theranostic capabilities. 
Future works 
A complete, optimal design of heat-focused nanodevices for tumor 
treatments must include analysis on more parameters. A final model 
describing the shape influence on power lost is still missing. Indeed, it is 
confirmed that cubic iron oxides (IOs) perform better compared to spherical 
counterparts with comparable size. However, the reason remains a matter of 
discussion. Mathematical models for theoretical predictions (modeling) of 
these enhancements would significantly reduce the required concentration for 
an effective local hyperthermia. Other investigations should also consider 
synergy with other co-adjuvant treatments and patient-specific considerations.  
Also, the only available method to test particle efficiency is by indirect 
recording of overall temperature in diffused media which generate 
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inaccuracies. A very elegant solution to this problem was recently proposed by 
the group of Pellegrino [138]. This method can be used for temperature 
mapping at a single particle level, during AMF exposure; this would allow a 
better characterization of particles heating properties and, most importantly, 
unleash direct observation and validation of proposed mathematical models. 
As for Magnetic NanoFlakes (MNFs) synthesis process, it only 
represents a very first step in the development of a proper multifunctional 
nanodevice. An optimization process will include testing of different polymer, 
loaded with drug for a triggered release, and also test effect of surface 
functionalization. Additionally while enhancement in SAR has been quantified, 
corresponding changes or enhancement in relaxivity is yet to be investigated. 
Finally, it should be verified that similar levels of enhancements of particles 
performances can be reproduced using different SPIOs formulations. 
Dragging of macrophages, which have internalized IOs loaded HNPs, is 
successfully achieved in a preliminary study. This suggests that properly 
targeted particles can be used as drivers to lead bigger cells on specific routes, 
and/or promote interactions between bigger bodies.  
Proper in-vivo studies will continue testing the MNFs particles to 
improve accumulation (histology tests and organs post-digestion), imaging 
capabilities (direct MRI imaging), and to further enhance hyperthermia 
treatment. 
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